Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS6663639 B1
Tipo de publicaciónConcesión
Número de solicitudUS 09/520,273
Fecha de publicación16 Dic 2003
Fecha de presentación7 Mar 2000
Fecha de prioridad22 Jun 1999
TarifaPagadas
También publicado comoUS6773441, US7736373, US7896893, US8057494, US20040193184, US20050033328, US20090198254
Número de publicación09520273, 520273, US 6663639 B1, US 6663639B1, US-B1-6663639, US6663639 B1, US6663639B1
InventoresMichael D. Laufer, Jeffrey C. Cerier, Amos G. Cruz
Cesionario originalNdo Surgical, Inc.
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Methods and devices for tissue reconfiguration
US 6663639 B1
Resumen
Methods and devices are provided for reconfiguring a tissue within a hollow body organ using an entirely endoscopic approach in order to effectively reduce flow of fluid contents into a second hollow body organ in fluid communication with the first.
Imágenes(30)
Previous page
Next page
Reclamaciones(94)
What is claimed is:
1. An endoscopic method of reconfiguring tissue within a first hollow organ of a subject, wherein the first hollow organ has an inner surface, an outer surface, a lumen defined by the inner surface, and at least one junction connecting the first hollow organ in fluid communication with a second hollow organ, the method comprising:
simultaneously engaging at least two portions of at least the inner surface of the first hollow organ;
manipulating at least one of the engaged portions of the first hollow organ to create a reconfigured portion of the first hollow organ from within; and
permanently securing the reconfigured portion of the first hollow organ with at least one tissue fixation device so as to substantially retain the shape of the reconfigured portion;
wherein securing the reconfigured portion of the first hollow organ does not involve securing the reconfigured portion of the first hollow organ to tissue of the second hollow organ.
2. The method of claim 1 wherein any one or combination of the engaging, manipulating and securing steps is repeated at least once.
3. The method of claim 1 further comprising endoscopic visualization of at least a portion of at least one of the steps of engaging, manipulating, and securing.
4. The method of claim 1 wherein the permanently secured reconfigured portion comprises a conformation selected from the group consisting of a bulge, a mound, a plication, a ridge, a jellyroll, a tube, a cone, and a horn.
5. The method of claim 1 wherein the permanently secured reconfigured portion comprises a tissue fold.
6. The method of claim 1 wherein the permanently secured reconfigured portion comprises a tissue bulge.
7. The method of claim 1 wherein the engaging is reversible and essentially atraumatic.
8. The method of claim 1 wherein the engaging comprises clamping.
9. The method of claim 1 wherein the engaging comprises applying a corkscrew-like retractor to at least the inner surface of the first hollow organ.
10. The method of claim 1 wherein the securing comprises application of a biocompatible tissue fixation device selected from the group consisting of a staple, a clip, a tack, a rivet, a two-part fastener, a helical fastener, a suture, and a T-bar suture.
11. The method of claim 1 wherein the securing involves only tissue of the first hollow organ.
12. The method of claim 1 wherein the securing comprises stapling.
13. The method of claim 1 wherein the securing comprises application of a two-part fastener.
14. The method of claim 1 wherein the engaging and the securing are performed using a single instrument.
15. The method of claim 1 wherein the first hollow organ is selected from the group consisting of esophagus, stomach, intestine, bladder, ureter, urethra, uterus, vagina, heart, and vein.
16. The method of claim 1 wherein the permanently secured reconfigured portion is effective to reduce flow of contents of the first hollow organ into the second hollow organ.
17. An endoscopic method for treating gastroesophageal reflux in a subject comprising:
simultaneously engaging at least two independent points of at least the inner surface of the stomach of a subject, near an opening of the esophagus of the subject into the stomach;
manipulating at least one of the engaged points of the stomach to create a reconfigured portion of the stomach from within; and
permanently securing the reconfigured portion of the stomach with at least one tissue fixation device so that the shape of the reconfigured portion is retained,
wherein the steps of engaging, manipulating, and securing are all performed endoluminally.
18. The method of claim 17 wherein any one or combination of the engaging, manipulating, and securing is repeated at least once.
19. The method of claim 17 wherein the engaging, manipulating, and securing are performed at a time of making an endoscopic diagnosis of GERD.
20. The method of claim 17 wherein the permanently secured reconfigured portion comprises a conformation selected from the group consisting of a bulge, a mound, a plication, a ridge, a jellyroll, a tube, a cone, and a horn.
21. The method of claim 17 wherein the permanently secured reconfigured portion comprises a tissue fold.
22. The method of claim 17 wherein the permanently secured reconfigured portion comprises a tissue bulge.
23. The method of claim 17 wherein the engaging is reversible and essentially atraumatic.
24. The method of claim 17 wherein the engaging comprises clamping.
25. The method of claim 17 wherein the engaging comprises applying a corkscrew-like retractor to at least the inner surface of the stomach.
26. The method of claim 17 wherein the securing comprises application of a biocompatible tissue fixation device selected from the group consisting of a staple, a clip, a tack, a rivet, a two-part fastener, a helical fastener, a suture, and a T-bar suture.
27. The method of claim 17 wherein the securing comprises stapling.
28. The method of claim 17 wherein the securing comprises application of a two-part fastener.
29. The method of claim 17 wherein the engaging and the securing are performed using a single instrument.
30. The method of claim 17 further comprising measuring tissue pressure at the GEJ in association with at least one of the steps of engaging, manipulating, and securing.
31. The method of claim 17 further comprising measuring yield pressure in association with at least one of the steps of engaging, manipulating, and securing.
32. The method of claim 17 wherein the permanently secured reconfigured portion is effective to increase yield pressure by an amount effective to reduce passage of gastric contents from the stomach to the esophagus.
33. The method of claim 17 wherein the permanently secured reconfigured portion is effective to reduce reflux of gastric contents into the subject's esophagus.
34. The method of claim 17 wherein the permanently secured reconfigured portion is effective to reduce symptoms related to gastroesophageal reflux.
35. The method of claim 17 wherein said manipulating step comprises moving the points toward each other to create the tissue bulge.
36. The method of claim 17 wherein said engaging step comprises the step of engaging the two points adjacent to a flap portion of an existing flap valve, the two points straddling the flap portion of the flap valve and on the same side of the opening.
37. The method of claim 36 wherein said manipulating step comprises moving the two points toward one another to create a bulge that displaces the flap portion toward the opening of the esophagus into the stomach.
38. An endoscopic method for treating gastroesophageal reflux in a subject comprising:
engaging at least the inner surface of the stomach at at least one portion near an opening of the esophagus of the subject into the stomach on one side of the opening of the esophagus into the stomach;
manipulating the at least one engaged portion of the stomach to create a reconfigured portion of the stomach comprising a flap portion of a flap valve including moving tissue of the inner surface of the stomach that is engaged at the at least one portion on one side of the opening of the esophagus into the stomach in said engaging step toward an opposite side of the opening of the esophagus into the stomach to form a flap; and
permanently securing the reconfigured portion of the stomach with at least one tissue fixation device so that the shape of the reconfigured portion is retained,
wherein the steps of engaging, manipulating, and securing are all performed endoscopically.
39. The method of claim 38 wherein any one or combination of the engaging, manipulating, and securing is repeated at least once.
40. The method of claim 38 wherein the reconfigured portion comprises an augmented gastroesophageal flap valve.
41. The method of claim 38 wherein the reconfigured portion comprises a new gastroesophageal flap valve.
42. The method of claim 38 wherein the engaging is reversible and essentially atraumatic.
43. The method of claim 38 wherein the engaging comprises clamping.
44. The method of claim 38 wherein the engaging comprises applying a corkscrew-like retractor to at least the inner surface of the stomach.
45. The method of claim 38 wherein the securing comprises application of a biocompatible tissue fixation device selected from the group consisting of a staple, a clip, a tack, a rivet, a two-part fastener, a helical fastener, a suture, and a T-bar suture.
46. The method of claim 38 wherein the securing comprises stapling.
47. The method of claim 38 wherein the securing comprises application of a two-part fastener.
48. The method of claim 38 wherein the engaging and the securing are performed using a single instrument.
49. The method of claim 38 further comprising measuring tissue pressure at the GEJ in association with at least one of the steps of engaging, manipulating, and securing.
50. The method of claim 38 further comprising measuring yield pressure in association with at least one of the steps of engaging, manipulating, and securing.
51. The method of claim 38 wherein the securing does not involve tissue of the subject's esophagus.
52. The method of claim 38 wherein the flap valve is effective to increase competence of the GEJ by an amount effective to reduce passage of gastric contents from the stomach to the esophagus.
53. The method of claim 38 wherein the flap valve is effective to reduce symptoms related to gastroesophageal reflux.
54. The method of claim 38 wherein said permanently securing step comprises the step of applying at least one tissue fixation device to the flap formed by said manipulating step at a point on the side of the opening of the esophagus into the stomach opposite the side of tissue engagement.
55. An endoscopic method for treating gastroesophageal reflux in a subject comprising:
engaging at least one portion of at least the inner surface of the stomach of a subject, near an opening of the esophagus of the subject into the stomach;
manipulating at least one engaged portion of the stomach to create a reconfigured portion of the stomach comprising a flap portion of a flap valve and bringing sealing surfaces of the flap valve into closer approximation; and
permanently securing the reconfigured portion of the stomach with at least one tissue fixation device so that the shape of the reconfigured portion is retained and is effective for reducing gastroesophageal reflux,
wherein the steps of engaging, manipulating, and securing are all performed endoluminally.
56. The method of claim 55 wherein any one or combination of the engaging, reconfiguring, and securing is repeated at least once.
57. The method of claim 55 further comprising endoscopic visualization of at least a portion of at least one of the steps of engaging, reconfiguring, and securing.
58. The method of claim 55 wherein the engaging, reconfiguring, and securing are performed at the time of making an endoscopic diagnosis of GERD.
59. The method of claim 55 wherein the engaging is reversible and essentially atraumatic.
60. The method of claim 55 wherein the engaging comprises clamping.
61. The method of claim 55 wherein the engaging comprises applying a corkscrew-like retractor to at least the inner surface of the stomach.
62. The method of claim 55 wherein the securing comprises application of a biocompatible tissue fixation device selected from the group consisting of a staple, a clip, a tack, a rivet, a two-part fastener, a helical fastener, a suture, and a T-bar suture.
63. The method of claim 55 wherein the securing comprises stapling.
64. The method of claim 55 wherein the securing comprises application of a two-part fastener.
65. The method of claim 55 wherein the engaging and the securing are performed using a single instrument.
66. The method of claim 55 further comprising measuring tissue pressure at the GEJ in association with at least one of the steps of engaging, manipulating, and securing.
67. The method of claim 55 further comprising measuring yield pressure in association with at least one of the steps of engaging, manipulating, and securing.
68. The method of claim 55 wherein the securing involves only tissue of the stomach.
69. The method of claim 55 wherein the permanently secured reconfigured portion is effective to increase yield pressure of the GEJ of the subject by an amount effective to reduce flow of contents of the stomach into the esophagus of the subject.
70. The method of claim 55 wherein the permanently secured reconfigured portion is effective to reduce symptoms related to reflux of contents of the stomach into the esophagus of the subject.
71. The method of claim 70 wherein the symptoms related to reflux are reduced by at least 50 percent compared to the symptoms in the absence of the permanently secured reconfigured portion.
72. The method of claim 55 wherein said engaging step comprises the steps of:
deploying into the stomach of a subject at least two spaced, tissue engaging elements;
positioning the tissue engaging elements adjacent to and on one side of the opening of the esophagus into the stomach; and
engaging stomach tissue with the tissue engaging elements.
73. The method of claim 72 wherein said reconfiguring step comprises the steps of:
while the tissue engaging elements are engaging tissue in the stomach, moving at least two-spaced tissue engaging elements toward an opposite side of the opening of the esophagus into the stomach to create a pair of evaginations straddling the opening of the esophagus into the stomach.
74. The method of claim 73 wherein said permanently securing step comprises the step of securing the two evaginations to one another by passing a fixation device from the inside of one evagination into a wall of the other evagination.
75. The method of claim 74 further comprising the step of capturing an aspect of an extrinsic tissue structure between the two evaginations.
76. The method of claim 75 wherein the extrinsic tissue structure comprises a median arcuate ligament of a diaphragm.
77. A method for treating gastroesophageal reflux in a subject comprising:
engaging at least two portions of at least the inner surface of the stomach of a subject, the two portions being spaced from one another and disposed near an opening of the esophagus of the subject into the stomach;
reconfiguring at least a portion of the stomach to assume a new shape by bringing the engaged portions toward one another; and
permanently securing the reconfigured portion of the stomach with at least one tissue fixation device so as to retain the shape of the reconfigured portion.
78. The method of claim 77 wherein the steps of engaging, reconfiguring, and securing are performed endoscopically.
79. The method of claim 77 wherein the at least two portions spaced from one another are engaged by at least two distinct tissue engaging devices.
80. The method of claim 77 wherein the engaging is reversible and essentially atraumatic.
81. The method of claim 77 wherein the engaging comprises clamping.
82. The method of claim 77 wherein the engaging comprises application of a corkscrew-like retractor.
83. The method of claim 77 wherein the shape assumed by the reconfigured portion comprises a plication.
84. The method of claim 77 wherein the shape assumed by the reconfigured portion comprises a bulge.
85. The method of claim 77 wherein the shape assumed by the reconfigured portion is effective for bringing sealing surfaces at an opening of the esophagus into the stomach into closer apposition.
86. The method of claim 77 wherein the securing comprises stapling.
87. The method of claim 77 wherein the securing comprises application of a two-part fastener.
88. The method of claim 77 further comprising measuring tissue pressure at the GEJ in association with at least one of the steps of engaging, reconfiguring, and securing.
89. The method of claim 77 further comprising measuring yield pressure in association with at least one of the steps of engaging, reconfiguring, and securing.
90. An endoscopic method for treating gastroesophageal reflux in a subject comprising:
engaging first and second points on a side of an opening of the esophagus of a subject into the stomach, wherein the first point is disposed adjacent to a flap portion of the existing flap valve and the second point is disposed on a side of the opening of the esophagus into the stomach opposite the flap portion;
manipulating at least one engaged portion of the stomach to create a reconfigured portion effective to bring sealing surfaces of the existing flap valve into a closer approximation; and
permanently securing the reconfigured portion of the stomach with at least one tissue fixation device so that the shape of the reconfigured portion is retained,
wherein the steps of engaging, manipulating, and securing are all performed endoscopically.
91. The method of claim 90 wherein said manipulating step comprises moving the two points toward one another to create a bulge that displaces the flap portion towed the opening of the esophagus into the stomach.
92. An endoscopic method for treating gastroesophageal reflux in a subject comprising:
engaging at least the inner surface of the stomach at first and second points near an opening of the esophagus of the subject into the stomach on a first side of the opening of the esophagus into the stomach, wherein the first point is disposed adjacent to a flap portion of the existing flap valve and the second point is disposed on a side of the opening of the esophagus into the stomach opposite the flap portion;
engaging at least the inner surface of the stomach at first and second additional points on a second side of the opening of the esophagus into the stomach, wherein the first additional point is disposed adjacent to the flap portion of the existing flap valve and the second additional point is disposed on a side of the opening of the esophagus into the stomach opposite the flap portion;
manipulating at least one engaged portion of the stomach to create a reconfigured portion effective to bring sealing surfaces of an existing flap valve into a closer approximation; and
permanently securing the reconfigured portion of the stomach with at least one tissue fixation device so that the shape of the reconfigured portion is retained,
wherein the steps of engaging, manipulating, and securing are all performed endoscopically.
93. The method of claim 92 wherein said manipulating step comprises the steps of:
moving together the first and second points on the first side of the opening of the esophagus into the stomach; and
moving together the first and second additional points on the second side of the opening of the esophagus into the stomach.
94. The method of claim 17 wherein the manipulating is effective to bring sealing surfaces of an existing flap valve into a closer approximation.
Descripción

This application claims the benefit of provisional Application Ser. No. 60,140,492 filed Jun. 22, 1999.

FIELD OF THE INVENTION

This invention relates generally to endoscopic methods and devices for reconfiguring tissue within a hollow body organ and more particularly to such methods and apparatus used to reduce the reflux of contents of one hollow organ into another hollow organ.

BACKGROUND OF THE INVENTION

Gastroesophageal reflux disease (GERD) is a common upper-gastrointestinal disorder with a prevalence of approximately 5 percent in the Western world. GERD is a condition in which acidic contents of the stomach flow inappropriately from the stomach into the esophagus. GERD causes heartburn when accompanied by irritation of the esophagus. Chronic irritation of the esophagus leads to inflammation of the esophagus, known as esophagitis. In addition to esophagitis, complications of GERD include Barrett's esophagus, esophageal stricture, intractable vomiting, asthma, chronic bronchitis, and aspiration pneumonia. Approximately 25 percent of individuals with GERD fail pharmacological therapy and become candidates for a surgical anti-reflux procedure. The estimated total direct and indirect costs of GERD treatment in the United States are in excess of 100 billion dollars annually.

The focus of attention in understanding the pathophysiology of GERD has for many years been the lower esophageal sphincter (LES), thought to be a ring of smooth muscle located at the gastroesophageal junction (GEJ) near where the lower esophagus communicates with the entrance to the stomach. Normally the LES allows food to pass from the esophagus to the stomach, while otherwise remaining closed, thus preventing reflux. Closure of the LES is an active process, requiring a combination of proper mechanics and intact innervation. Additionally, the diaphragm may act on the esophagus normally to keep it closed at the LES.

Backflow of gastric contents into the esophagus results when gastric pressure is sufficient to overcome the pressure gradient that normally exists at the GEJ or when gravity acting on the contents is sufficient to cause flow through the GEJ. This situation arises when the gastric pressure is elevated or when the competence of the LES is compromised. Gastric pressure is elevated in association with eating, bending at the waist or squatting, constriction of the waist by clothing, obesity, pregnancy, partial or complete bowel obstruction, etc. Gravitational effects occur when a patient with this condition becomes recumbent. Incompetence of the LES can be functional or anatomic in origin. Functional incompetence is associated with hiatus hernia, denervation, myopathy, scleroderma, and chemical or pharmacological influences (smoking, smooth muscle relaxants, caffeine, fatty foods, and peppermint). Dodds W J et al. 1982, N Engl J Med 307:1547-52. Anatomic incompetence is associated with congenital malformation, surgical disruption (myotomy, balloon dilatation or bouginage), neoplasm, etc.

Recently, the existence and importance of the gastroesophageal flap valve have come to be appreciated as a significant first line of defense against GERD. Hill L D et al. 1996, Gastrointest Endosc 44:541-7; Contractor Q Q et al. 1999, J Clin Gasroenterol 28:233-7. The gastroesophageal flap valve appears as a semicircular musculo-mucosal fold extending for 3-4 cm along the lesser curvature of the stomach.

The recent advent of a range of new medications for the treatment of reflux disease, including omerprazole and other proton pump inhibitors, high-dose histamine-2 antagonists, and cisapride, has markedly improved the treatment for many patients. Despite these dramatic advances in medical therapy for GERD, they are not always fully satisfactory. There are cost implications of very long-term treatment of patients with these relatively expensive medications (Spechler S J 1992, N Engl J Med 326:786-92) as well as some concern about the safety of very long-term potent acid suppression with the possibility of gastrin (G) cell hyperplasia (Solcia E et al. 1993, Aliment Pharmacol Ther 7(supp. 1):25-8; Poynter D et al. 1985, Gut 26:1284-95; Lambert R et al. 1993, Gastroenterology 104:1554-7) from prolonged hypergastrinemia. Furthermore, a significant number of patients are resistant to or intolerant of available medical therapy (Klinkenberg-Knol E C and Meuwissen S G 1988 Aliment Pharmacol Ther 2:221-7; Klinkenberg-Knol E C and Meuwissen S G 1989, Digestion 1:47-53), and many patients relapse quickly if medical treatment is stopped. Hetzel D J et al. 1988, Gastroenterology 95:903-12.

Although several open surgical procedures are effective in the treatment of GERD, they are now used in a minority of patients because of the major nature of the surgery and the occasionally poor results achieved. These occasionally poor results may be due in part to the lack of clear patient selection criteria. At least ten different open antireflux operations have been described and used in patients. Jamieson G G, ed. 1988, Surgery of the Oesophagus London: Churchill Livingstone, 233-45. The principal types of operations have included some type of reconstruction of the antireflux barrier, which may include a gastric wrap, as in classic Nissen fundoplication (Nissen R 1956, Schweiz Med Wochenschr 86:590-2; Polk H C et al. 1971, Ann Surg 173:775-81; DeMeester T R et al. 1986, Ann Surg 204:9-20), Toupet fundoplication (Thor K 1988, The modified Toupet procedure, In: Hill L et al., The Esophagus, Medical and Surgical Management, WB Saunders Co., pp 135-8) or Belsey repair (Skinner D B et al. 1967, J Thorac Cardiovasc Surg 53:33-54), a nongastric wrap, e.g., the Angelchik prosthesis (Starling J R et al. 1982, Ann Surg 195:686-91), a ligamentum teres cardiopexy (Rampal M et al. 1967, Presse Medicale 75:617-9; Pedinielli L et al. 1964, Ann Chir 18:1461-74; Janssen I M et al. 1993, Br J Surg 80:875-8), and fixation of a part of the stomach to an immobile structure, e.g., the preaortic fascia, as in the Hill repair (Hill L D 1967, Ann Surg 166:681-92) or the anterior rectus sheath (as in an anterior gastropexy). Boerma J 1969, Surgery 65:884-9. Several of these operations also include a crural repair of the esophageal hiatus in the diaphragm. In the 1950s, Collis popularized gastroplasty as an alternative operation for gastroesophageal reflux, especially for those patients with a short esophagus. Collis J L 1957, J Thoracic Surg 34:768-78. He created a gastric tube (neoesophagus) in continuity with the shortened esophagus, which effectively increased the total and intra-abdominal length of the esophagus and resulted in clinical improvement in patients with GERD. Collis J L 1968, Am J Surg 115:465-71.

With the development of minimally invasive surgical techniques, especially laparoscopic cholecystectomy in the early 1990s, a few of the open surgical antireflux operations were developed and modified for use with laparoscopy. The laparoscopic Nissen fundoplication is currently the most widely used laparoscopic antireflux operation. Jamieson G G et al. 1994, Ann Surg 220: 137-45. Other laparoscopic antireflux operations, for example the laparoscopic Hill repair (Kraemer S J et al. 1994, Gastrointest Endosc 40:155-9), ligamentum teres cardiopexy (Nathanson L K et al. 1991, Br J Surg 78:947-51), and some modified operations with partial wraps (Cuschieri A et al. 1993, Surg Endosc 7:505-10; McKernan J B 1994, Surg Endosc 8:851-6) have also been reported. These laparoscopic antireflux operations appear to produce good results with relatively short, pain-free postoperative recovery times in most patients. Falk G L et al. 1992, Aust N Z J Surg 62:969-72. However, laparoscopic operations themselves remain lengthy, technically demanding procedures requiring general anesthesia, best reserved for a small subset of patients with severe symptoms refractory to proton pump inhibitor or other medical treatments for GERD.

Attempts at laparoscopic transgastric antireflux surgery in animals have also been reported. Jennings et al. developed a method of forming a gastric fundoplication by creating an esophageal intussusception and plicating the gastric fundus around the esophagus using a purpose-built stapling device. Jennings R W et al. 1992, J Laparoendosc Surg 2:207-13.

There have been some attempts to treat reflux disease at flexible endoscopy. An early endoscopic approach to control GERD was to inject collagen in and around the LES. O'Connor and Lehman treated ten patients by this method with some success, although some patients required further injections at the LES to maintain syrmptomatic relief. O'Connor K W and Lehman G A 1988, Gastrointest Endosc 34:106-12. Donahue et al. demonstrated that GERD, induced with high-dose intravenous atropine in dogs, could be controlled by injection of 5 percent morruhate sodium in the proximal gastric region 1 to 2 cm distal to the LES at flexible endoscopy and suggested that the proximal gastric sclerosis caused by the injection formed an effective antireflux barrier. Donahue P E et al. 1990, Gastrointest Endosc 36:253-6; Donahue P E et al. 1992, World J Surg 16:343-6. Endoscopic proximal gastric sclerosis induced by Nd:YAG laser has also been shown to create a potential reflux barrier in dogs. McGouran R C M and Galloway J M 1990, Gastrointest Endosc 36:439-43. Recently, Harrison et al. described a method of forming a flap valve at the GEJ by creating an intussusception of esophagus into stomach. U.S. Pat. No. 5,403,326. LoCicero disclosed an endoscopic method for reducing gastroesophageal reflux in U.S. Pat. No. 5,887,594.

SUMMARY OF THE INVENTION

In a first aspect, the present invention relates to endoscopic methods and instruments for reconfiguring tissue within a hollow body organ of a subject. The methods and instruments of this invention are useful for reducing flow of fluid contents from a first hollow organ into a second hollow organ in fluid communication with the first hollow organ. The methods and instruments of this invention permit an entirely endoluminal technique for reconfiguring tissue within a hollow body organ of a subject.

In the first aspect, the method includes the steps of engaging at least a portion of the inner surface of the first hollow organ, manipulating the engaged portion of tissue so as to reconfigure at least a part of the first hollow organ from within, and permanently securing the reconfigured portion so that the reconfigured tissue retains the new configuration achieved by manipulation of the engaged portion.

In some embodiments of the invention, the reconfiguring can comprise an invagination of a portion of the wall of the hollow organ. The invaginated portion can assume the shape of one of a number of various possible geometries. The new configuration of tissue is then permanently fixed by the application of at least one tissue fixation device.

In other embodiments of this aspect of the invention, the reconfiguring can comprise an evagination of a portion of the wall of the hollow organ. In certain embodiments the evaginated portion can be affixed to another portion of the same organ. In other embodiments the evaginated portion may be fixed to another evaginated portion of the same organ.

The method may involve repetition of at least one of the engaging, reconfiguring, and securing steps.

In some embodiments the permanently secured reconfigured tissue comprises a tissue fold. In other embodiments the permanently secured reconfigured tissue comprises a shape that may be described as a bulge or a mound. In yet other embodiments the permanently secured reconfigured tissue can take the form of a ridge, a jellyroll, a tube, a cone, or a horn.

In some embodiments the step of engaging tissue includes nonpenetrating techniques. Nonpenetrating methods of engaging tissue include clamping and applying a suction.

In some embodiments the step of securing includes applying at least one biocompatible tissue fixation device selected from the group consisting of a staple, a tack, a rivet, a two-part fastener, a helical fastener, a suture, and a T-bar suture. In other embodiments the step of securing involves application of a tissue adhesive.

According to some embodiments of this aspect of the invention, the permanently secured reconfigured tissue is effective to reduce flow of contents of the first hollow organ into the second hollow organ.

In some embodiments of this aspect of the invention the method includes the step of endoscopic visualization of at least a portion of the engaged tissue. In other embodiments of this aspect of the invention the method includes the step of endoscopic visualization of at least a portion of at least one of the steps of engaging, reconfiguring, and securing.

In a second aspect the invention relates to an endoscopic method of treating and/or preventing GERD. The method includes the steps of engaging at least a portion of the inner surface of the stomach, manipulating the engaged portion of stomach tissue so as to reconfigure at least a part of the stomach from within, and permanently securing the reconfigured portion so that the reconfigured tissue retains the new configuration achieved by manipulation of the engaged portion. In a preferred embodiment of this aspect of the invention the securing does not involve tissue of the esophagus.

Major advantages of the invention as it relates to the treatment of GERD include recreation of normal anatomy, reduced morbidity, increased efficacy, and technical ease in clinical practice. In particular, the method reestablishes normal gastroesophageal flap valve anatomy, avoids safety concerns related to methods which involve stapling through the esophagus, avoids possible functional compromise associated with placement of tissue fixation devices directly in sealing surfaces, and can be performed by an endoscopist with the subject sedated but not under general anesthesia.

According to some embodiments of this aspect of the invention, the permanently secured reconfigured tissue is effective to reduce flow of contents of the stomach into the esophagus while allowing the normal passage of food from the esophagus into the stomach. In some embodiments of this aspect of the invention, the permanently secured reconfigured tissue is effective to reduce gastroesophageal reflux.

According to some embodiments of this aspect of the invention, the permanently secured reconfigured tissue is effective to reduce symptoms related to gastroesophageal reflux. In certain embodiments of this aspect of the invention, symptoms related to gastroesophageal reflux are reduced by at least 50 percent.

In some embodiments of this aspect of the invention, the permanently secured reconfigured tissue is effective to increase the GEJ yield pressure. In preferred embodiments the GEJ yield pressure is increased by an amount effective to reduce flow of contents of the stomach into the esophagus under normal, non-vomiting situations.

In a preferred embodiment of this aspect of the invention the steps of engaging, manipulating, and securing are performed at the time of making an endoscopic diagnosis of GERD.

Three different methods are disclosed for treating GERD depending upon the endoscopic evaluation. The various methods are all directed to the recreation of normal tissue geometry which favors the unidirectional passage of fluids and food from esophagus to stomach and restricts reflux of stomach contents into esophagus. A first method is employed if there is a sufficient flap at the GEJ, but the sealing surfaces are not in apposition. In one embodiment of this method, a layer of the stomach wall is engaged at two or more independent points near the opening of the esophagus into the stomach on the side of the aperture at the GEJ opposite the existing flap portion of the gastroesophageal flap valve. These engaged points are moved toward each other to create a tissue bulge or mound that displaces the sealing surfaces closer together, e.g., displaces the valve seat toward the flap. This bulge or mound is subsequently retained in place using a tissue fixation device. In another embodiment of this method, stomach tissue is engaged at two points near the opening of the esophagus into the stomach on the same side of the aperture at the GEJ as the flap. This tissue is squeezed into closer approximation to create a bulge that displaces the sealing surfaces closer together, e.g., displaces the flap toward the valve seat. The resulting bulge or mound is fixed by at least one tissue fixation device. In yet another embodiment of this method, stomach tissue is engaged at two or more pairs of independent points, one pair of points disposed on one side of the aperture at the GEJ and the other pair of points disposed on the contralateral side of the aperture at the GEJ. The points of each individual pair of points of tissue engagement are moved toward one another and fixed by at least one tissue fixation device to bring and to hold the sealing surfaces in closer and effective apposition.

In a method of treating GERD used where there is not a sufficient flap of tissue, either because an existing flap is too small or because there is no flap present at all, but the sealing surfaces are in apposition, a portion of the inner aspect of stomach wall is engaged at one or more points on one side of the aperture at the GEJ manipulated toward the opposite side of the aperture at the GEJ to augment or recreate a flap. The augmented or recreated flap may be either rectangular or triangular or any other suitable shape. Fixation devices are employed to hold the augmented or recreated flap over the aperture at the GEJ. Alternatively, the tissue may be invaginated and tissue fixation devices are deployed at the base of the flap to fix it prior to any further manipulation. Thereafter, the flap is manipulated to cover the GEJ.

Where there is not a sufficient flap of tissue and the sealing surfaces are not in apposition, another method is used for treating GERD. Two sites on the inner aspect of the stomach wall and adjacent to the GEJ are engaged by two tissue engagement device elements. The elements are moved in relation to the GEJ to create a pair of evaginations straddling the GEJ. These two evaginations are caused to come into apposition, and tissue securing devices are deployed to fix one evagination to the other. In a preferred embodiment of this method, an aspect of the diaphragm is sandwiched and fixed between the two evaginations of the stomach. This latter embodiment of this method can also be used for repairing a hiatus hernia.

In a third aspect of the invention, instruments are provided for performing the foregoing methods. A preferred instrument includes all of the necessary tools on one instrument which can be manipulated externally of the stomach. Preferably, the instrument is delivered endoscopically through the mouth. The instrument includes an inner and outer tube and two stapler arms pivotally mounted to the inner tube. Disposed on the distal end of the stapler arms are a pair of small graspers disposed in apposition. A stapler cartridge is disposed also on the end of one stapler-arm, while an anvil is disposed on the distal end of the other stapler arm. Mounted in an articulating manner to the outer tube are a pair of grasper arms which extend-oppositely from the stapler arms.

Another instrument utilized for engaging and manipulating the tissue includes a pair of toothed, interengaging rollers which can be introduced endoscopically. A further example of a tissue engaging and manipulating device is a suction device, such as a tube having an opening on one end or on one side and apparatus for reducing the pressure within the tube sufficient to allow the tube to engage tissue at the opening.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention will be more fully appreciated from the following detailed description when taken in conjunction with the accompanying drawings in which:

FIG. 1 is a pictorial representation of a stomach in anteroposterior cutaway view in which a gastroscope has been advanced through the lumen of the esophagus into the lumen of the stomach and retroflexed to visualize the GEJ;

FIG. 2 is a pictorial representation of a stomach as in FIG. 1 with a tissue engaging device within the lumen of the stomach;

FIG. 3 is a pictorial representation of a stomach as in FIG. 2, where the tissue engaging device has engaged and invaginated a portion of the stomach wall;

FIG. 4 is a pictorial representation of a sectional view of a stomach looking toward the opening of the esophagus into the stomach, showing two points of tissue engagement and arrows indicating the direction of force to be applied to engaged tissue to create a tissue fold covering the GEJ;

FIG. 5 is a pictorial representation of a sectional view of a stomach looking toward the opening of the esophagus into the stomach, showing the invaginated rectangular tissue fold covering the GEJ;

FIG. 6 is a cross-sectional view of a stomach looking toward the opening of the esophagus into the stomach, showing an invaginated triangular tissue fold covering the GEJ;

FIG. 7 is a pictorial representation of a stomach as in FIG. 3, with an endoscopic tissue securing device also introduced into the lumen of the stomach via the esophagus;

FIG. 8 is a pictorial representation of a stomach in anteroposterior cutaway view following deployment of one tissue fixation device to maintain the invaginated portion of stomach wall;

FIG. 9 is a pictorial representation of a stomach depicting a row of tissue fixation devices;

FIG. 10 is a pictorial representation of a stomach depicting three parallel rows of tissue fixation devices;

FIG. 11 is a pictorial representation of a stomach depicting nonparallel rows of tissue fixation devices;

FIG. 12 is a pictorial representation of a stomach depicting a triangular array of tissue fixation devices;

FIG. 13 is a pictorial representation of a stomach depicting multiple tissue fixation devices in curved rows;

FIG. 14 is a cross-sectional view of a stomach looking toward the opening of the esophagus into the stomach, showing a normal gastroesophageal flap valve;

FIG. 15 is a cross-sectional view of a stomach looking toward the opening of the esophagus into the stomach, showing an invaginated tissue bulge opposite the flap of the gastroesophageal flap valve;

FIG. 16 is a cross-section view of a stomach looking toward the opening of the esophagus into the stomach, illustrating one method of bringing together sealing surfaces and the existing gastroesophageal flap valve;

FIG. 17 is a cross-sectional view of a stomach looking toward the opening of the esophagus into the stomach, showing a method of augmenting an existing gastroesophageal flap valve;

FIG. 18 is a cross-sectional view of a stomach looking toward the opening of the esophagus into the stomach, showing fixation of an invaginated fold of tissue at its base with three tissue fixing devices;

FIG. 19 is a cross-sectional view of a stomach looking toward the opening of the esophagus into the stomach, showing a rectangular invaginated fold of tissue fixed at its base covering the GEJ;

FIG. 20 is a pictorial representation of the stomach of FIG. 1 in which a combination tissue engaging device/tissue securing device has been advanced into the lumen of the stomach via the lumen of the esophagus;

FIG. 21 is a pictorial representation of the stomach of FIG. 20 following creation and apposition of two evaginations of stomach wall;

FIG. 22 is a pictorial representation of the stomach of FIG. 20 in exterior view showing the direction of manipulation of stomach tissue from within;

FIG. 23 is a pictorial representation of the stomach of FIG. 22 showing fixation between evaginations of stomach wall;

FIG. 24 is a pictorial representation of the stomach of FIG. 23 showing fixation of an aspect of the diaphragm between evaginations of stomach wall;

FIG. 25 is a side-elevation view of a preferred embodiment of a tissue engaging, manipulating and fixing device of this invention;

FIG. 26 is a side-elevation, schematic view of a portion of the device of FIG. 25;

FIG. 27 is a pictorial representation of a corkscrew-like tissue engagement device;

FIG. 28 is a pictorial representation of (top) an open-ended tube suction tissue engagement device, (middle) a blind-ended tube suction tissue engagement device, and (bottom) an open-ended and flanged tube suction tissue engagement device;

FIG. 29 is a pictorial representation of a two-part tissue fixation device;

FIG. 30 is a partial side, elevation, schematic view of the device of FIG. 25;

FIG. 31 is a side-elevation view of a preferred embodiment of a tissue engaging, manipulating and fixing device of this invention as in FIG. 25, further including pressure monitoring tubes; and

FIG. 32 is a side, elevation view of the device of FIG. 25 illustrating one position of the arms thereof;

FIG. 33 is a side, elevation view of the device of FIG. 25 showing yet another position of the arms thereof;

FIG. 34 is a side, elevation view of the device of FIG. 25 showing yet another position of the arms thereof;

FIG. 35 is a side, elevation view of the device of FIG. 25 showing another position of the arms thereof;

FIG. 36 is a schematic, partially cut-away side view of a stomach illustrating use of the device of FIG. 25 therein; and

FIG. 37 is a perspective view of a tissue engaging device fitted with opposing rollers.

DETAILED DESCRIPTION OF THE INVENTION

Various aspects of the invention will now be described with reference to the figures. While this invention has particular application to reducing gastroesophageal reflux, the methods and devices of the invention are not limited to this particular application alone, however, for they can be applied to a stomach as well as to other hollow body organs as discussed below.

A. Endoscopic Methods for Reconfiguring Tissue Within a Hollow Body Organ

In one aspect, the present invention provides endoscopic methods for reconfiguring tissue within a hollow body organ. This aspect of the invention will now be described with particular reference to FIGS. 1-13 which disclose the steps of the method of the invention as applied to the stomach for purposes of illustration only. The method of the invention may be applied to any hollow organ, as defined below. In a broad sense, the methods include at least the steps of engaging a portion of the inner surface of the hollow organ to be reconfigured, manipulating the engaged portion of tissue to create the reconfiguration, and fixing the manipulated tissue to retain the reconfiguration achieved in the manipulation. The methods may also include the step of endoscopic visualization during all or part of the procedure. Details of the shapes that can be assumed by the reconfigured tissue are discussed below.

As used herein, “endoscopic method” refers to a technique for performing a medical procedure on a subject in which access to the tissue to be treated is gained via an endoluminal approach. In a preferred embodiment an endoscopic method is performed without a contemporaneous invasive approach involving a surgical incision to gain access to the area of treatment. This preferred embodiment embraces use of at least one intravenous catheter for the administration of crystalloid or colloid fluids or medication to the subject, but does not require placement through the abdominal wall of an intraabdominal set of trocars, laparoscope, or the like.

The methods of the invention also contemplate gaining access to the interior of a subject's stomach via a gastrotomy or gastrostomy. Such methods, which retain the feature of involving minimally invasive access to tissue to be reconfigured, may be of particular value in situations where access via the esophagus is not possible due to distortion or disruption of normal oropharyngeal or proximal esophageal anatomy. Such methods may also be of particular value when a gastrotomy or gastrostomy is present for other medical reasons, such as for enteral feeding, for example.

As used herein, “hollow organ” refers to an organ of a subject's body which depends for its principal function upon its ability to receive and/or act as a conduit for liquid contents. A hollow organ typically is in fluid communication with another hollow organ and/or with the outside of the body. Many organs of the gastrointestinal and genitourinary tracts are classified as hollow viscus organs. These include stomach, gall bladder, uterus, and bladder. Other hollow organs which act more as fluid passageways include esophagus, small and large intestines, hepatic ducts, cystic duct, common bile duct, pancreatic duct, heart, veins, arteries, vagina, uterine (i.e., Fallopian) tubes, ureters, and urethra.

In the case of a stomach being the hollow organ, “liquid contents” includes any of the following: masticated food, imbibed liquid, chyme, gastric mucus, gastric acid, and other gastric secretions. In other contexts “liquid contents” can also include other body fluids such as intestinal contents, bile, exocrine pancreatic secretions, blood, and urine.

Endoscopic visualization. Endoscopic visualization can be used for all, at least a part, or none of the procedure. In certain preferred embodiments of the invention, the method is performed in conjunction with endoscopic visualization of at least the engaged portion of tissue. Typically, as shown in FIG. 1, a first step in the method of the invention includes advancing an endoscope 14 into the interior or lumen 13 of a first hollow organ 10. Preferably, but not necessarily, endoscope 14 is advanced into the interior of first hollow organ 10 by way of a lumen 11 of a second hollow organ 12 in fluid communication with the first hollow organ 10.

Endoscopes are well known in the art. Viewing endoscopic instruments typically are equipped with a lighting element and a viewing element enabling an operator to view the interior of the accessed body cavity. Viewing endoscopic instruments often also include at least one fluid channel suitable for introducing and/or withdrawing a fluid, gas, or medicament, and a working channel suitable to accommodate a remotely operated surgical tool such as a needle, a grasper, a biopsy device, a brush, an electrocautery electrode, and the like. Acceptable viewing elements include fiberoptic-assisted direct visualization, television array, and video array endoscopes. Endoscope 14 can be introduced into lumen 13 of the first hollow organ for at least one aspect of the procedure and removed for at least one other aspect of the procedure. Accordingly, a viewing endoscope 14 can be introduced, removed, and reintroduced for any one or for any combination of steps of the method of the invention.

For the purposes of the invention, a viewing endoscope can be an instrument separate from any other instrument employed in the practice of the method of the invention. Alternatively, a viewing endoscope can work cooperatively with at least one other instrument used in the practice of the invention by, for example, the at least one other instrument's cooperatively positioning the endoscope. In other embodiments, a viewing endoscope can be incorporated into a tissue engaging device, at least a portion of a tissue fixing device, or part of a combined tissue engaging and tissue securing device.

It should be noted that existing flexible endoscopes may not be sufficiently rigid when flexed to serve as the working platform for performing the types of stomach tissue manipulation described below. The types of pushing, pulling, and side-to-side manipulations to be performed in the vicinity of the opening of the esophagus into the stomach require a degree of mechanical leverage for which a retroflexed gastroscope normally cannot serve as an adequate fulcrum. To perform these manipulations in a stomach, an endoscope may be used, for viewing purposes, in conjunction with a specially structured instrument such as described below. In applications where rigid endoscopes may be used, the methods may be practiced without such specially structured instruments.

In other embodiments of the invention, the method is performed at least in part with non-endoscopic visualization of the tissue engaged. Non-endoscopic methods of visualization include techniques well known in the art, such as, without limitation, fluoroscopy, either with or without the use of a suitable radiographic contrast agent, and ultrasound. In some embodiments the procedure can be performed without any endoscopic visualization.

Engaging. An early step of this aspect of the invention is engaging the selected portion of an inner surface 16 of first hollow organ 10, as shown in FIG. 2.

As used herein, the term “engaging” refers to an act of reversibly penetrating, gripping, tweezing, holding, pressing, clamping, sucking, or otherwise contacting a tissue in a mechanical fashion so as to establish a physical connection with the tissue. In certain preferred embodiments of the invention the engagement of tissue occurs reversibly and essentially atraumatically.

For purposes of this invention, an endoscopic tissue engaging device is understood to have a proximal end and a distal end interconnected by an elongate portion of suitable length and rigidity to permit an operator, in contact with and control of the proximal end, to gain remote access to the interior of a body cavity with the distal end of the endoscopic tissue engaging device. Furthermore, the operator of an endoscopic tissue engaging device is understood to be able to actuate a tissue engaging element disposed at the distal end by manipulation of at least one aspect of a controlling mechanism disposed at the proximal end and operatively connected to the tissue engaging element disposed at the distal end.

The tissue engaging device in some embodiments can be a separate instrument unto itself. In other embodiments the tissue engaging device can be used in combination with another endoscopic instrument. In yet other embodiments the tissue engaging device can be an element of a combination endoscopic instrument. In a preferred embodiment the tissue engaging device is an element of an endoscopic instrument which also incorporates a tissue securing device (see below).

As used herein, an “engaged portion” shall refer to a segment of tissue actually engaged by a device used to engage the tissue.

In certain preferred embodiments the engaged portion involves just the inner lining of the first hollow organ 10. For example the engaged portion can involve only the mucosa in a stomach. In other embodiments the engaged portion can involve the inner lining and at least one additional tissue layer of first hollow organ 10. Again with reference to the stomach, the reconfigured portion can involve the mucosa and at least one layer of muscular wall, up to and including the full thickness of the stomach wall.

In certain preferred embodiments the tissue engaging device can engage tissue in a reversible and essentially atraumatic manner. Engagement of tissue in such embodiments is effective for performing subsequent steps of the method but also allows release of engaged tissue in a manner which causes little or no disruption of tissue integrity.

For example, in a most preferred embodiment the tissue engagement device includes a novel corkscrew-type element, described below. Even though the sharpened end of the spiral corkscrew-type element pierces in order to engage tissue, when the spiral is removed by unscrewing it from tissue, it leaves a single discrete point of penetration which self-seals in the extremely pliable tissue lining of the stomach, much as does a hole made in the same tissue with a hypodermic needle.

In yet other embodiments the tissue engaging device can be a known clamping device. Examples of suitable endoscopic clamping devices are well known in the art, including, without limitation, endoscopic alligator grasping forceps (see FIG. 2), forked jaw grasping forceps, rat tooth grasping forceps, three-prong grasping forceps, tripod grasping forceps, fenestrated cup forceps, and ellipsoid fenestrated forceps. As used herein, each such endoscopic clamping device is considered to engage a single portion of tissue, i.e., all tissue contacted by the various jaws of a single clamping device is considered as a single point of tissue engagement.

In other preferred embodiments the tissue engaging device can be a novel suction device, as described below. Tissue is engaged when contacted with suction and released atraumatically when the suction is broken at a point other than the point of tissue engagement.

According to the above embodiments, the tissue engaging device can engage tissue for the purposes of side-to-side manipulation, twisting, pushing, or retracting tissue. In yet another embodiment a tissue engaging device may be the sharpened end of, for example, at least one leg of a surgical staple. According to this embodiment, the tissue engaging device can engage tissue for the purposes of side-to-side manipulation, twisting, or pushing, but not for retracting tissue.

In a preferred embodiment a tissue engaging device may be incorporated into a tissue manipulating device. In this embodiment, the elongate portion of the tissue engaging device is further structured to permit manipulation of tissue engaged by atraumatic grasping, suction, or piercing as above. In a most preferred embodiment, as discussed below, a novel single instrument incorporating both a tissue engaging and tissue manipulation device is structured to permit independent engagement of tissue at two or more points, and to permit manipulation of at least two points of tissue with respect to each other in any direction in three-dimensional space. The two or more independent points of tissue engagement typically are separated by at least 1 cm prior to tissue engagement.

In a preferred embodiment, an endoscopic tissue engaging device 18 is advanced into lumen 13 of first hollow organ 10, preferably via a lumen 11 of second hollow organ 12. In FIG. 2 first hollow organ 10 is shown as a stomach and second hollow organ 12 is shown as an esophagus in fluid communication with organ 10. Distal end 17 of endoscope 14 and a distal end of tissue engaging device 18 are shown in position in FIG. 2 after they have been advanced into lumen 13 of organ 10 via the lumen 11 of organ 12. The related portion of inner surface 16 of first hollow organ 10 is engaged with endoscopic tissue engaging device 18, which is described below.

In one preferred embodiment engaging is accomplished by gripping tissue with a known jawed forceps device 18 as illustrated schematically in FIG. 2. Device 18 includes opposed jaws 15 and 19 having teeth 23 or the like. The engaging force must be sufficient to maintain physical connection with the engaged portion of tissue when a tissue-deforming torque, push, or retraction is applied to the engaged tissue via the tissue engaging device, while at the same time the force distribution is sufficient to avoid piercing, tearing, or cutting the surface of the engaged portion.

In certain preferred embodiments of the invention the engagement involves simultaneous engagement of at least two distinct sites. This effect can be achieved by simultaneously applying at least two tissue engagement devices, e.g., two separate endoscopic forceps clamps, or applying a single tissue engagement device designed to engage tissue simultaneously at distinct sites. A device of the latter type is described below.

Release of the engaged portion is necessary in order to remove the engaging device from the hollow organ of the subject after having engaged the tissue. The engaged portion typically will participate in the reconfigured portion; i.e., the reconfigured tissue will typically comprise in some aspect, be it at a basal, apical, or intermediate position relative to the reconfigured portion as a whole, the tissue actually engaged by the engaging device in the course of reconfiguring.

Manipulating. In a subsequent step of the invention, the engaged portion of inner surface 16 of first hollow organ 10 is manipulated to reconfigure at least a portion of first hollow organ 10, as shown in FIG. 3. Inner surface 16 of first organ 10 is manipulated by device 18 to create a reconfigured portion 20. In the manipulating step a physical force is applied by device 18 to the engaged portion of tissue of inner surface 16 effective for pushing, pulling, twisting, rolling, folding, gathering, or otherwise displacing tissue from its original position and/or configuration prior to application of such force. In preferred embodiments, tissue in adjacent continuity with the portion actually engaged will undergo at least some degree of physical deformation from its original conformation in proportion to the magnitude and direction of force applied to the engaged portion. Manipulation of engaged tissue may be used to create an invagination, an evagination, or a combination of invagination and evagination of at least inner layer 16 of first hollow organ 10.

In one embodiment of this aspect of the invention, manipulation of the engaged portion of inner surface 16 of first hollow organ 10 is achieved by applying traction force or torquing force to create reconfigured portion 20, which is an invagination. Traction force can be linear, such as achieved by pulling. Alternatively, traction force can be nonlinear, such as can be achieved by winding engaging tissue onto a spool.

As used herein, “invaginated portion” or “invagination” refers to a region of tissue displaced toward the interior cavity of the hollow organ as a combined result of engaging and manipulating. The particular shape assumed by the invaginated portion will depend on factors including the geometry of the engaged portion, the anatomy of the engaged organ, the plasticity of the segment of the organ engaged, and the direction and magnitude of the force applied.

Examples of forming invaginations that assume the shape of a flap or fold are shown in FIGS. 4-6. FIG. 4 depicts a cross-sectional view of a stomach looking toward the opening of the esophagus into the stomach 36. Also shown in FIG. 4 is the opening of the duodenum into the stomach 31. In FIG. 4, inner surface 16 of stomach 10 is engaged at two points 37 and 39 on one side of opening of the esophagus into the stomach 36, flanking opening of the esophagus into the stomach 36. The engaged tissue is then manipulated in the direction indicated by the arrows 38, i.e., in a direction generally toward and across the opening of the esophagus into the stomach 36 from points of engagement 37 and 39. FIG. 5 depicts a generally rectangular flap 40 created by the engaging and manipulating steps shown in FIG. 4. The flap 40 is fixed at points 35, which are in the direction of or across the aperture of opening of the esophagus into the stomach 36 relative to points of engagement 37 and 39. The opening of the esophagus into the stomach 36 is at least partially covered by rectangular flap 40. Two tissue fixation devices each pass through at least two layers of stomach wall: the layer or layers forming fold 40 and at least the lining 16 of the stomach wall near the opening of the esophagus into the stomach 36. The size and tightness of the fold depend on the location of points of fixation 35 relative to the points of engagement 37 and 39 and the position of the opening of the esophagus into the stomach 36.

A method of making an alternative flap configuration is depicted in FIG. 6. Inner surface 16 of stomach 10 is engaged at a single point 41 near opening of the esophagus into the stomach 36. The engaged tissue is then manipulated in the direction indicated by the arrow 48, i.e., in a direction generally toward and across the opening of the esophagus into the stomach 36 from point of tissue engagement 41. FIG. 6 depicts a triangular flap 50 created by the engaging and manipulating steps shown in FIG. 6. The opening of the esophagus into the stomach 36 is at least partially covered by flap 50. The fold 50 is fixed at a single point 51 generally across the opening of the esophagus into the stomach 36 from point of tissue engagement 41. A single tissue fixation device passes through at least two layers of stomach wall: the layer or layers forming the fold 50 and the lining 16 of the stomach wall near the opening of the esophagus into the stomach 36. The size and tightness of the fold 50 depend on the location of the point of fixation 51 relative to the point of engagement 41 and the position of the opening of the esophagus into the stomach 36.

It is emphasized that the rectangular and triangular shapes described above are highly schematic. Due to the plasticity of the tissue involved, the actual configuration of tissue achieved by such methods may not appear so definitively rectangular or triangular. Nevertheless, it is useful to think in terms of these shapes or structures for the purposes of conceptualizing the methods used to achieve the desired functional effects, i.e., the inhibition of reflux.

Reconfigured portion 20 can assume any of a range of alternative shapes, including without limitation, a flap, a fold, a bulge, a mound, a ridge, a roll (“jellyroll”), a tube, a papilla, or a cone. The mechanics of mobility of the shaped tissue depend on factors including, for example, the size, shape, thickness, radius, position, and composition of the involved tissue, as well as the shape of the fastener or fasteners, and the placement position of the fastener or fasteners.

In certain embodiments, the invagination forming reconfigured portion 20 can take the shape of a tissue bulge. As used herein, “tissue bulge” refers to a gathered up or heaped up mound of tissue with a base and an apex relative to the contour of tissue from which it arises. The circumference at its base can be irregular or it can be substantially regular, e.g., substantially elliptical, substantially circular, substantially triangular, or substantially rectangular. A tissue bulge resembles, when viewed from within the hollow organ, a lump or a mass or a papilla. A mound of tissue forming a tissue bulge is to be distinguished from a flap or fold of tissue in that it need not have distinct opposing surfaces or sides. As viewed from within the hollow organ, a tissue bulge can be smooth, dimpled, or furrowed.

According to an embodiment of this aspect of the invention, manipulation can entail bringing into apposition at least two points of tissue which are independently engaged by at least one tissue engaging device.

According to yet another embodiment of this aspect of the invention, combinations of tissue invaginations are created. Thus for example a flap and a bulge can be created in combination. Other embodiments include, without limitation, at least two flaps; at least two bulges; at least two rolls; a roll and a bulge; etc. Combinations of tissue invaginations can be created essentially contemporaneously or consecutively.

According to yet another embodiment of this aspect of the invention, manipulation of the engaged portion of inner surface 16 of first hollow organ 10 can be achieved by applying a leading or pushing force so as to create, from within, an outward protrusion of the first hollow organ (not shown). According to this method reconfigured portion 20 is an evagination rather than an invagination. An evaginated portion can assume any of a number of shapes as viewed from the exterior of the hollow organ, including, without limitation, a bulge, a lump, a ridge, a flap, a fold, a tube, a horn, and a cone. As also viewed from the exterior of the hollow organ, a tissue evagination can be smooth, dimpled, or furrowed. The circumference at its base can be irregular or it can be substantially regular, e.g., substantially elliptical, substantially circular, substantially triangular, or substantially rectangular. The method also contemplates the formation of a plurality of evaginations, which may be created either simultaneously or sequentially. At least one evagination can be combined with at least one invagination.

In some embodiments reconfigured portion 20 involves just the inner lining of the first hollow organ 10. For example reconfigured portion 20 can involve only the mucosa in a stomach. In other embodiments reconfigured portion 20 can involve the inner lining and at least one additional tissue layer of first hollow organ 10. Again with reference to the stomach, the reconfigured portion can involve the mucosa and at least one layer of muscular wall, up to and including the full thickness of the stomach wall.

Securing. After the manipulating step, a subsequent step involves permanently securing reconfigured portion 20 of first hollow organ 10 to effect a substantially permanent retention of the shape of reconfigured portion 20, as shown in FIGS. 7 and 8. While reconfigured portion 20 of organ 10 is maintained under control of the operator through the manipulating force applied to the engaged portion of tissue via the tissue engaging device 18, the operator causes a distal effector end 21 of a tissue securing device 22 (described below) to come into contact with reconfigured portion 20. Distal effector end 21 of tissue securing device 22 includes at least one biocompatible tissue fixation device 24 (described below) and is structured for application of at least one biocompatible tissue fixation device 24 into reconfigured portion 20. Tissue securing device 22 is advanced into lumen 13 of first hollow organ 10 before, along with, or after the tissue engaging device 18; thereafter, tissue securing device 22 is actuated to apply at least one biocompatible tissue fixation device 24 to permanently secure or fix the shape of reconfigured portion 20.

As used herein, “permanently secure” refers to directed placement of at least one biocompatible tissue fixation device effective for stabilizing tissue in a desired position. Permanently securing is preferably accomplished from within lumen 13 of first hollow organ 10. “Permanently” means for as long as there is clinical utility. This definition contemplates the intentional, active removal of a tissue fixation device by a practitioner based on his professional judgment. When permanently securing is accomplished by applying at least one resorbable tissue fixation device, the invention contemplates the formation of tissue adhesion arising at the site of or as a result of the presence of the applied resorbable tissue fixation device during the time such device remains intact. “Permanently securing” contemplates that such tissue adhesion is effective to maintain the configuration of the reconfigured tissue after resorption of the resorbable tissue fixation device.

According to a preferred embodiment of the invention, securing an invaginated portion of a hollow body organ in a new position preferably does not involve tissue extrinsic to the first hollow body organ. Thus the method of this invention preferably does not involve securing tissue of the first hollow body organ 10 to tissue of a second hollow body organ 12 in fluid communication with the first. In the particular instance where the first hollow body organ 10 is a stomach and the second hollow organ 12 is an esophagus, according to this embodiment, stomach tissue is secured only to stomach tissue, and not to tissue of the esophagus.

The tissue fixation device 24 of this invention is a mechanical entity useful for stabilizing a particular configuration of at least one tissue. A tissue fixation device 24 is deployed or applied to a tissue by a tissue securing means 22 structured to deliver the tissue fixation device 24.

For purposes of the invention, tissue securing device 22 is understood to have a proximal end and a distal end 21 interconnected by an elongate portion of suitable length to permit an operator, in contact with and control of the proximal end, to gain remote access to the interior of a body cavity with the distal end 21 of the endoscopic tissue engaging device 22. Furthermore, the operator of an endoscopic tissue engaging device 22 is understood to be able to actuate an effector element disposed at the distal end 21 by manipulation of at least one aspect of a controlling mechanism disposed at the proximal end and operatively connected to the effector element disposed at the distal end 21. The effector element can be structured to deliver at least one tissue fixation device 24, tissue adhesive, or radio frequency (RF) energy into tissue contacted with the effector element.

The tissue securing device in some embodiments can be a separate instrument unto itself. In other embodiments the tissue securing device can be used in combination with another endoscopic instrument. In yet other embodiments the tissue securing device can be an element of a combination endoscopic instrument. In a preferred embodiment, the tissue securing device is an element of an endoscopic tissue shaping instrument which also incorporates a tissue engaging device.

In a preferred embodiment tissue fixation device 24 is a biocompatible staple and tissue securing device 22 is an endoscopic surgical stapler. Examples of surgical staplers are well known in the art, including those disclosed in U.S. Pat. Nos. 5,040,715 and 5,376,095. Stapling devices can be anviled or one-sided. A biocompatible staple is commonly made of non-resorbable material such as titanium or stainless steel, but other materials, including resorbable materials, are embraced by the invention. In other embodiments of the invention tissue fixation device 24 can be a biocompatible clip, tack, rivet, two-part fastener, helical fastener, T-bar suture, suture, or the like, examples of which are well known in the art. In preferred embodiments tissue fixation device 24 is non-resorbable.

In certain embodiments, tissue fixation device 24 penetrates only an internal layer of first hollow organ 10. The internal layer can be, for example, the mucosa lining the interior of the stomach. Alternatively, tissue fixation device 24 penetrates both internal and at least one additional layer of first hollow organ 10. The at least one additional layer can be, for example, a muscle layer of the stomach wall. The combined inner layer and at least one additional layer constitute either a partial-thickness layer or a full-thickness layer. The securing step of this method includes, for example, fixation of an inner layer to a partial-thickness layer. This step also includes, for example, fixation of an inner layer to a full-thickness layer. In certain other methods, in the securing step, the tissue fixation device penetrates (1) a partial-thickness layer and (2) a full-thickness layer, or two full-thickness layers of the first hollow organ 10. This latter securing step fixes, for example, a full-thickness invagination in which two or more distinct regions of the exterior surface of the first hollow organ are brought into apposition (not shown).

In yet other securing steps where more than one tissue fixation device 24 is used, there can be any combination of tissue fixation devices 24 penetrating any combination of layers. For example a first tissue fixation device 24 penetrating a partial-thickness layer can be used in combination with a second tissue fixation device penetrating an inner layer alone. As another example, a first tissue fixation device 24 penetrating both an inner layer and a partial-thickness layer can be used in combination with a second tissue fixation device 24 penetrating an inner layer and a full-thickness layer. These and other possible combinations of tissue fixation devices used to fix combinations of tissue layers are intended to be encompassed by the invention.

FIGS. 9-13 illustrate various geometric patterns that can be used when the at least one tissue fixation device 24 is a biocompatible staple. When more than one tissue fixation device 24 is deployed, the tissue fixation devices 24 can be delivered sequentially or simultaneously. Examples of geometric patterns include a line (FIG. 9); two or more parallel lines (FIG. 10); two or more nonparallel lines, including a “T” (FIG. 11) and a cross; at least one polygon, including a triangle (FIG. 12); at least one arc, including two or more curves (FIG. 13); at least one circle. The purposes of alternate configurations are to spread the stresses due to fixation over a greater area of tissue; provide a fail-safe situation, i.e., maintain fixation even if one of the tissue fixation devices should fail; create and maintain tissue shape and positioning for optimal clinical effect; and encourage healing, by creating multiple holes in tissue, causing bleeding or fibrocyte migration.

Achievement of the desired reconfiguring of tissue can require two or more cycles of engaging, manipulating, and securing. For example, in a particular instance the desired size or shape to be effected might not be fully achieved in a single cycle of engaging, manipulating, and securing. The method also contemplates releasing the engaged portion of the first hollow organ 10 and optionally re-engaging that portion or engaging another portion and then manipulating and permanently securing the portion thus engaged.

The shape of tissue assumed by the secured, reconfigured portion 20 may be effective to restrict flow of liquid contents of the first hollow organ 10 into the second hollow organ 12, while allowing normal flow antegrade from the second hollow organ 12 into the first hollow organ 10. Examples of undesired flow from one hollow organ into a contiguous second hollow organ include gastroesophageal reflux, reflux of urine from the urinary bladder retrograde into a ureter, regurgitant blood flow from one chamber to another within the heart, and blood flow through an atrial or ventricular septal defect.

The permanently secured reconfigured portion 20 preferably is effective to restrict reflux of contents of the first hollow organ 10 into the second hollow organ 12. Reconfigured portions may be a valve that hinders or restricts passage of contents from organ 10 to organ 12. Preferably the valve operates as a one-way valve. In a preferred embodiment of the invention the valve created to accomplish the objectives is a flap valve. Examples of such valves occurring naturally in humans include aortic, mitral, pulmonary, and tricuspid valves of the heart, the gastroesophageal flap valve, the ileocecal valve, the epiglottis, and valves in veins. Flap valves are also normally found at the junction between the urinary bladder and the ureters. Other types of valves which could be created according to the method of this invention include nipple valves and multi-leafed valves.

In the case of the stomach it is most desirable that any valve interconnecting the stomach and the esophagus function effectively to restrict the flow of gastric contents into the esophagus under normal circumstances. The ideal valve should function in such a manner so as to permit, under appropriate circumstances, release of gas from the stomach into the esophagus, regurgitation of stomach contents into the esophagus, and interventional aspiration of stomach contents. In the normal individual the gastroesophageal flap valve achieves this desired degree of functional discrimination.

The desired effect of the resulting secured, reconfigured portion 20 includes at least one of the following: reduction in the frequency of unwanted backflow; reduction in the volume of unwanted backflow or reflux; reduction of symptoms related to unwanted backflow or reflux; and increasing yield pressure between the first hollow organ 10 and the second hollow organ 12. Any such desired effect is measured relative to reflux under similar circumstances, e.g., in relation to recumbency, inversion, coughing, sneezing, etc., before the combined steps of reconfiguring and securing. Any such effect is achieved by the ability of the secured, reconfigured portion 20 to impede flow of liquid across a junction from the first hollow organ 10 into the second hollow organ 12, such as the GEJ proximal to opening of the esophagus into the stomach 36.

In a preferred embodiment the secured, reconfigured portion 20 reduces the frequency of episodes of unwanted backflow by at least 50 percent. Most preferably the frequency of unwanted backflow episodes is reduced by about 100 percent.

In another preferred embodiment the secured, reconfigured portion 20 reduces the volume of unwanted fluid backflow by at least 20 percent. In a more preferred embodiment the volume of unwanted fluid backflow is reduced by at least 50 percent.

In another preferred embodiment the secured, reconfigured portion 20 is effective for increasing the competence of the GEJ. As used herein, “competence of the GEJ” refers to the ability of the GEJ to limit the flow of contents of the stomach into the esophagus while allowing the normal passage of food from the esophagus to the stomach. A fully competent GEJ would completely limit the flow of contents of the stomach into the esophagus while allowing the normal passage of food from the esophagus to the stomach.

As used herein, the words “symptoms of reflux” refer to subjective experiences of a subject as well as objective clinical signs attributable to backflow of contents of a distal hollow organ into the lumen of a proximal hollow organ in fluid communication with the first. In a preferred embodiment the symptoms of reflux are related to gastroesophageal reflux.

As used herein, “effective to reduce symptoms of reflux” refers to substantially reducing the frequency, number, and/or severity of symptoms arising as a result of episodic or chronic reflux. In a preferred embodiment the frequency of symptoms of reflux is reduced by at least 50 percent. In another preferred embodiment the severity of symptoms of reflux is reduced by at least 50 percent. In yet another embodiment the number of symptoms of reflux is reduced by at least one.

The secured, reconfigured portion 20 also may be effective for increasing the yield pressure of the junction connecting first hollow organ 10 to second hollow organ 12, such as the GEJ proximal to the opening of the esophagus into the stomach 36. As used herein, the term “yield pressure” refers to the intraluminal pressure of first hollow organ 10 which overcomes a pressure gradient otherwise maintained between first hollow organ 10 and second hollow organ 12. In other words, the yield pressure is the change in pressure which is sufficient to cause flow of contents of first hollow organ 10 into the lumen 11 of the second hollow organ 12. As applied to the yield pressure of the GEJ, yield pressure is the maximum pressure reached inside the stomach prior to refluxive flow when it is infused with gas or liquid, minus the pressure at rest in the stomach. Normal yield pressures of the GEJ fall within the range of 7-15 mm Hg in healthy human subjects (McGouran R C M et al. 1988, Gut 29:275-8 ; Ismail T et al. 1995, Br J Surg 82:943-7), ≧5 mm Hg in subjects with GERD (McGouran R C M et al. 1988, supra; McGouran R C M et al. 1989, Gut 30:1309-12; Ismail T et al. 1995, supra), and >14 mm Hg in subjects with GERD following successful reflux surgery (McGouran R C M et al. 1989, supra; Ismail T. et al. 1995, supra).

As used herein, “effective to increase yield pressure” refers to an objectively measurable increase in the yield pressure over the pretreatment yield pressure. In a preferred embodiment of the invention, the yield pressure is increased to at least 75 percent of normal. Practice of the invention can include but does not require objective measurement of an increase in yield pressure.

Bench testing was conducted using an excised pig stomach and attached esophagus to demonstrate the principle of creating a bulge to prevent gastroesophageal reflux. The duodenum was clamped, an incision was made in the greater curvature of the stomach, and the stomach was inverted and filled with water. Water was observed to flow under the force of gravity from the stomach to the esophagus in a steady stream. A bulge was made in the wall of the stomach within one inch of the opening of the esophagus into the stomach. The bulge was fixed in place with a staple. The stomach was then refilled with water. No water was observed to flow under the force of gravity from the stomach to the esophagus following this procedure. A one-half inch diameter cylinder was passed through the esophagus and opening of the esophagus into the stomach both before and after creation of the bulge, indicating that the bulge did not close the lumen of the opening of the esophagus into the stomach.

To demonstrate the in vivo effect of creating a bulge on yield pressure of a stomach, a pig was placed under general anesthesia and surgical access to the stomach was gained via an abdominal incision. Two small punctures were made in the stomach, through which a tube for saline inflow was placed into one, and a pressure-monitoring catheter was placed into the other. Purse-string sutures were placed around each incision to secure the tubes and seal the stomach tissue to prevent leakage. After clamping the pylorus, saline was infused into the stomach through the inflow tube until the stomach was full. The stomach was then squeezed by hand and the maximum pressure obtained was observed on equipment attached to the pressure monitoring catheter. Average maximum yield pressure obtained was 32 mm Hg.

The stomach was drained and an incision was made in the wall of the stomach to provide access for instrumentation into the stomach. A bulge was created within one inch of the opening of the esophagus into the stomach and fixed in position with a staple. The incision was closed with suture and the stomach refilled with saline. The stomach was then squeezed again by hand and the maximum pressure obtained observed as before. Average maximum yield pressure obtained after creation of the bulge was 57 mm Hg. Yield pressure thus increased nearly 80 percent over baseline.

B. Endoscopic Methods for Reconfiguring Tissue Within a Stomach to Treat GERD

In another aspect, the invention relates to endoscopic methods for reconfiguring tissue within a stomach to treat GERD. The methods are based upon the observation that a flap of stomach tissue covers the aperture of the esophagus as it enters the stomach, forming a flap valve which provides an effective barrier to reflux of liquid contents of the stomach. An effective flap valve functions as a one-way valve allowing free passage of swallowed liquids and solids from the esophagus into the stomach, but not vice versa, while permitting appropriate escape of gas from the stomach into the esophagus, e.g., during belching.

As used herein, a “flap valve” has an aperture and at least two sealing surfaces which, when properly apposed, effectively close the aperture. In a preferred embodiment, at least one of the sealing surfaces is provided by a mobile flap or ridge of tissue. In its closed position, the sealing surface of the flap contacts at least one other sealing surface, including either another flap or a valve seat, in such a manner as to form an effective closure or seal around the aperture.

In certain preferred embodiments a competent flap valve can function as a one-way valve, favoring flow past the valve in one direction and limiting flow past the valve in the opposite direction. As applied to a stomach, a competent flap valve should favor free flow of swallowed materials from esophagus 12 into stomach 10 and limit free flow of liquid contents from stomach 10 into esophagus 12. In a normal subject such a flap valve opens to permit a swallowed bolus to pass from esophagus 12 into stomach 10, but the flap valve otherwise normally remains closed, preventing reflux of liquid contents from stomach 10 into esophagus 12.

FIG. 14 depicts the configuration of a normal gastroesophageal flap valve 70 in a stomach 10 having an inner surface 16. Here flap portion 67 and valve seat 69 furnish the requisite sealing surfaces. In this view taken from the perspective of the interior of the stomach looking toward the opening of the esophagus into the stomach 36, the flap portion 67 of valve 70 is to the right, covering opening of the esophagus into the stomach 36, and the seat 69 of the valve is to the left of and beneath the covering flap. As used herein in reference to a stomach 10, a flap valve 70 shall be considered to “cover” the opening of the esophagus into the stomach 36 even though flap valve 70, being within the stomach 10, is caudal or inferior to the opening of the esophagus into the stomach 36.

Two factors may make a flap valve 70 incompetent. One factor is the absence of a sufficient flap of tissue 67. The opening of the esophagus into the stomach 36 cannot be effectively closed if a sufficient flap portion 67 is not present to form a seal against at least one other sealing surface 69. The flap 67 can be either be too small or simply absent altogether. The second factor is the effective apposition of sealing surfaces. The opening of the esophagus into the stomach 36 cannot be effectively closed, even if a sufficient flap portion 67 is present, if the sealing surfaces cannot be properly apposed. As used herein, sealing surfaces are properly “apposed” when their mutual contact causes the surfaces to form an effective barrier to reflux.

In clinical application, the existence or appearance of a gastroesophageal flap valve and the apposition of sealing surfaces are typically evaluated by endoscopic visualization in which the examining endoscope is retroflexed to view the opening of the esophagus into the stomach. The shaft of the endoscope proximal to the retroflexed segment traverses the opening and thus the valve and sealing surfaces are viewed in the context of their contact with the shaft of the endoscope. By way of example, Hill and colleagues developed the following grading system to describe the appearance of the flap valve as thus viewed: Grade I, in which there is a prominent fold of tissue extending along the shaft of the endoscope and closely apposed to the endoscope through all phases of respiration; Grade II, in which the fold is less prominent and occasionally opening and closing around the endoscope during respiration; Grade III, in which a fold is present but is neither prominent nor in close contact with the endoscope; and Grade IV, in which there is no fold present and the opening is agape about the endoscope. Hill L D et al. 1996, Gastrointest Endosc 44:541-7. Following the conventions provided by this general scheme, it is evident that sealing surfaces can be classified as apposed in Grade I. Not evident under this scheme, but nonetheless possible, sealing surfaces can be apposed in any situation, regardless of the presence or absence of any fold of tissue, provided there is continuous contact between the entire circumference of the endoscope shaft and tissue at the junction between the esophagus and the stomach.

The three methods described below are based upon the endoscopic appearance of the gastroesophageal flap valve (Table 1). A first method is directed to the clinical situation where there is a sufficient flap present but the sealing surfaces are not apposed. The method involves bringing the sealing surface and the flap closer together to tighten an existing flap valve. A second method is directed to the clinical situation where there is not a sufficient flap present but the sealing surfaces are apposed. The method involves the creation of a flap when there is none present, and alternatively, augmentation of an existing flap that is simply not large enough to cover the opening of the esophagus into the stomach. A third method is directed to the clinical situation where there is neither a sufficient flap present nor apposition of sealing surfaces. The method involves creating or augmenting a flap and bringing the flap or sealing surfaces closer together.

TABLE 1
Selection Criteria for Treating GERD Based upon Endoscopic Evaluation
ENDOSCOPIC EVALUATION
Is a sufficient flap Are the sealing TREATMENT
of tissue present? surfaces apposed? FIG. number Rationale
Yes Yes 14 No treatment required
Yes No 15, 16, 17 Brings sealing surfaces closer
together to tighten existing flap
value
No Yes 4, 5, 6, Creates or augments flap
18, 19
No No 20, 21, 22, Creates or augments flaps and
23, 24 brings sealing surfaces closer
together

In preferred embodiments of the invention, the three methods are performed at least in part with endoscopic visualization of stomach tissue for at least a part of one or more steps of the procedure. A preferred instrument for practicing the methods is disclosed in a separate section below. Other aspects of each of the three methods will now be discussed in more detail.

Sufficient Flap Present but Sealing Surfaces Inadequately Apposed: Creation of a Bulge or Tightening of Existing Flap Valve.

To remedy the problem where there is a sufficient flap present but the sealing surfaces are inadequately apposed, as shown in FIGS. 14 and 15, inner surface 16 of stomach 10, optionally including at least one underlying layer of stomach wall 34, is engaged at two or more independent points 73 and 75. Points of engagement 73 and 75 are disposed near the opening of the esophagus into the stomach 36, and on the side of the opening of the esophagus into the stomach 36 opposite the existing flap portion 67 of gastroesophageal flap valve 70. The positions of points of engagement 73 and 75 as shown in FIG. 15 are not meant to be limiting. As shown in FIG. 15, the positions of the points of engagement 73 and 75 and of the flap portion 67 are related by their disposition on opposite sides of the opening of the esophagus into the stomach 36. Accordingly, in clinical practice the positions of points of engagement 73 and 75 depend on the position of the flap portion 67, so that positions of points of engagement 73 and 75 and flap portion 67 could differ from those illustrated in FIG. 15 by rotation about the opening of the esophagus into the stomach 36 by as much as 180°. Engagement points 73 and 75 are then moved toward each other in the direction of the arrows shown in FIG. 15, creating a tissue bulge or mound 72. This action can be readily accomplished by a manipulation that involves squeezing. Tissue bulge 72 so created displaces the sealing surface of valve seat 69 toward the sealing surface of flap portion 67. This manipulated stomach tissue is fixed by deployment of at least one tissue fixation device, in the manner previously described, at tissue fixation point 77 to retain the shape of the tissue bulge 72. The tissue bulge 72 thus established permanently displaces the sealing surface of valve seat 69 toward the sealing surface of existing flap portion 67, effectively reconstituting a competent flap valve.

In another preferred embodiment of this method of the invention for remedying this problem, as shown in FIG. 16, stomach tissue is engaged at two points 77 and 79 near the opening of the esophagus into the stomach 36, on the same side of the opening of the esophagus into the stomach 36 as the existing flap portion 67 of gastroesophageal flap valve 70. The positions of points of engagement 77 and 79 as shown in FIG. 16 are not meant to be limiting. As shown in FIG. 16, the positions of the points of engagement 77 and 79 and of the flap portion 67 are related by their disposition on the same side of the opening of the esophagus into the stomach 36. Accordingly, in clinical practice the positions of points of engagement 77 and 79 depend on the position of the flap portion 67, so that positions of points of engagement 77 and 79 and flap portion 67 could differ from those illustrated in FIG. 16 by rotation about the opening of the esophagus into the stomach 36 by as much as 180°. Stomach tissue thus engaged at points 77 and 79 is manipulated to bring them into closer approximation. Such a manipulation creates a tissue bulge 81 that displaces the sealing surface provided by the flap portion 67 toward the sealing surface 69 on the opposite side of the opening of the esophagus into the stomach 36. Manipulated stomach tissue is fixed by deployment of at least one tissue fixation device at a tissue fixation point 83 to retain the shape of the tissue bulge 81. The tissue bulge 81 thus established permanently displaces the sealing surface provided by the existing flap portion 67 toward the sealing surface 69 on the opposite side of the opening of the esophagus into the stomach 36, effectively reconstituting a competent flap valve.

In yet another preferred embodiment of this method of the invention for remedying this problem, as shown in FIG. 17, stomach tissue is engaged at two or more pairs of independent points of tissue engagement, one pair defined by points 85 and 87, and another pair defined by points 89 and 91, near the opening of the esophagus into the stomach 36. The pairs of points are preferably disposed about the opening of the esophagus into the stomach 36 as follows: points 87 and 91 are on the same side as the flap portion 67, and points 85 and 89 are on the side of the opening of the esophagus into the stomach 36 opposite the flap portion 67. Accordingly, in clinical practice the positions of pairs of points of engagement depend on the position of the flap portion 67, so that positions of points of engagement 85, 87, 89, and 91 and flap portion 67 could differ from those illustrated in FIG. 17 by rotation about the opening of the esophagus into the stomach 36 by as much as 180°. Pair of points 85 and 87 may be engaged in one step of the method, and pair of points 89 and 91 may be engaged in a separate step of the method. Both points 85 and 87 and points 89 and 91 are independently manipulated in the direction of arrows 78 to bring points 85 and 87 into closer approximation, as well as to bring points 89 and 91 into closer approximation. At least two tissue fixation devices are deployed into stomach tissue at fixation points 93 and 95 in the manner previously discussed to retain the configuration achieved by the manipulation steps. Points 85 and 87 may be secured in one step of the method, and points 89 and 91 may be secured in a separate step of the method. The securing step in FIG. 17 may involve securing manipulated segments of tissue to each other (e.g., point 85 to point 87 and point 89 to point 91) or securing each independent manipulated segment to an unmanipulated portion. Unlike the embodiments above, this embodiment of this method need not necessarily result in the creation of a tissue bulge. However, this embodiment of this method also brings into apposition the sealing surfaces provided by the existing sufficient flap portion 67 and the sealing surface 69 on the opposite side of the opening of the esophagus into the stomach 36, effectively reconstituting a competent flap valve.

Sufficient Flap Not Present but Sealing Surfaces Adequately Apposed: Creation or Augmention of a Flap.

To remedy a situation where a sufficient flap is not present but the sealing surfaces are adequately apposed, the method already described with respect to FIGS. 20 and 21 is used. Stomach lining tissue 16, optionally including at least one underlying layer of stomach wall 34, is engaged at each point 37 and 39 near the opening of the esophagus into the stomach 36. Each point 37 and 39 must be positioned relative to opening of the esophagus into the stomach 36 so that subsequent manipulation and fixation steps result in a flap of stomach tissue suitably located and of sufficient area to cover at least a significant portion of opening of the esophagus into the stomach 36. Stomach tissue engaged at each point 37 and 39 is manipulated in the direction of arrows 38, i.e., in a direction toward opening of the esophagus into the stomach 36. The manipulations of the two points 37 and 39 shown in FIG. 4 may be accomplished sequentially or simultaneously, with the result of being the formation or augmentation of a substantially rectangular flap 40, as shown in FIG. 5. Stomach tissue is then secured to flap 40 at two fixation points 35 in the manner described previously, to maintain the substantially rectangular shape of the flap 40. The size and tightness of the flap 46 overlying the opening of the esophagus into the stomach 36 will vary based on the location of fixation points 35.

In an alternative embodiment of this method of the invention, shown in FIG. 6, the engagement and manipulation of a single point 41 in the direction of and across the opening of the esophagus into the stomach 36 results in the formation or augmentation of a substantially triangular flap 50. The substantially triangular flap 50 is secured by a single tissue fixation device to stomach tissue at tissue fixation point 51, in the manner previously described.

FIGS. 18-20 depict yet another alternative embodiment of this method of the invention for remedying the problem where there is not a sufficient flap but the sealing surfaces are adequately apposed. Lining tissue 16 is engaged at points 37 and 39 near and on one side of the opening of the esophagus into the stomach 36 and is invaginated to form a rectangular invaginated flap 60 (FIGS. 18 and 19). In the view of FIG. 18, the flap 60 is coming up out of the plane of the paper. After the engagement and manipulation steps shown in FIGS. 18 and 20, substantially rectangular flap 60 is fixed at its base with one or more tissue fixation devices 24. In a second step, depicted in FIG. 19, the free margin of the resulting flap 60 is pulled toward the opposite side of the opening of the esophagus into the stomach, positioned to cover the opening of the esophagus into the stomach 36, and fixed to stomach tissue in this position at one or more points 61 opposite the opening of the esophagus into the stomach 36 from the fixed base of the flap 60. Two tissue fixation devices each pass through at least two layers of stomach wall: the layer or layers forming the free margin of the flap 60 and at least the lining 16 of the stomach wall near opening of the esophagus into the stomach 36. The size and tightness of the flap depend on the location of points of fixation 61 relative to the base of the flap 60 and the position of the opening of the esophagus into the stomach 36.

Sufficient Flap Not Present and Sealing Surfaces Indequately Apposed: Creation or Augmentation of a Flap Combined with Bringing Sealing Surfaces Closer Together.

To remedy a situation where a sufficient flap of tissue is not already present and the sealing surfaces are not apposed, the stomach is plicated by forming and securing a pair of evaginations by a technique discussed below with respect to FIGS. 20-23.

As shown in FIG. 20, an endoscopic tissue engaging and tissue securing device 80 is introduced into the lumen 13 of the stomach 10 through lumen 11 of the esophagus 12. The distal end of the tissue engaging and securing device 80 includes a pair of tissue engaging elements 82 and a pair of tissue securing device elements 84 each disposed on a rotatably positionable arm 86. The two tissue securing device elements 84 can be two aspects of a single device, e.g., one element can be the anvil for the other. Alternatively, the two tissue securing device elements 84 can be two independent tissue securing devices unto themselves, e.g., two one-sided staplers. Motions of the two movable arms 86 can be dependently linked or can be independent of one another. The operator selects two sites on the lining 16 of the stomach and adjacent to opening of the esophagus into the stomach 36 to be engaged by the two tissue engaging elements 82.

FIG. 21 depicts how, having once engaged tissue at both sites, the operator then causes the arms 86 of the combination endoscopic tissue engaging device/tissue securing device 80 to swing, thereby creating a pair of evaginations 100 straddling the GEJ or distal esophagus. The two evaginations 100 are then caused to come into apposition, and the two tissue securing device elements 84 deploy at least one tissue fixation device to affix one evaginated portion 100 to the other.

FIG. 22 depicts an exterior view of stomach 10 (without the combination endoscopic tissue engaging device/tissue securing device 80) showing external counterparts 97 and 99 to the sites of tissue engagement (which are within the stomach) and the intended direction of tissue manipulation, as shown by arrows 88.

As discussed above, fixation is accomplished by placement from the lumen 13 of the stomach 10 of at least one tissue fixation device 24 through at least one full-thickness layer of stomach wall. FIG. 23 depicts an exterior view of stomach 10 following deployment of tissue fixation device 24 connecting apposing surfaces of evaginations 100 to create a partial gastric wrap. Tissue fixation device 24 is drawn in broken lines to indicate it is not visible from the outside of the stomach.

In one embodiment of this method, as depicted in FIGS. 20-22 and 24 and described in greater detail below, at least one of evaginations 100 is brought into contact with and secured to a tissue structure extrinsic to stomach 10. The tissue structure extrinsic to stomach is preferably an aspect of diaphragm 110. In one particularly preferred embodiment, an aspect of the diaphragm 110 is interposed between evaginations 100 and the mutual fixation of evaginations 100 with fixation device 24 simultaneously fixes the interposed aspect of diaphragm 110 to evaginations 100. Securing of a portion of stomach 10 near the GEJ to a relatively immobile structure extrinsic to stomach 10 creates or assures an effective barrier to reflux. Hill L D et al. (1990) Gastroenterol Clin North Am 19:745-75.

C. Endoscopic Methods for Repairing a Hiatus Hernia

In another aspect, this invention relates to endoscopic methods for repairing a hiatus hernia. The methods include engaging an aspect of the stomach from within, reducing the hernia (i.e., manipulating a portion of the stomach so engaged to reposition the herniated portion beneath the diaphragm, manipulating a portion of the stomach so engaged to bring it into contact with an aspect of a tissue structure extrinsic to the stomach, and securing a portion of a stomach to an aspect of a tissue structure extrinsic to the stomach.

According to a preferred embodiment of this aspect of the invention, the tissue extrinsic to the stomach is an aspect of the diaphragm 110. In a most preferred embodiment the tissue extrinsic to the stomach is the median arcuate ligament. In other preferred embodiments the tissue extrinsic to the stomach can involve tissue of the right crus, left crus, preaortic fascia, hepatogastric ligament, lesser omentum, or greater omentum.

A preferred method involves evagination, much like the method depicted in FIGS. 20-23, with the additional feature of engaging and fixing an aspect of a tissue structure extrinsic to the stomach between evaginated portions 100.

Preferably, as shown in FIGS. 20-22 and FIG. 24, although not necessarily, an aspect of the diaphragm 110 is sandwiched and secured by tissue fixation device 24 between the two evaginations 100 of the stomach wall. The preferred aspect of diaphragm 110 is a portion of the median arcuate ligament 112. This method achieves the combined effects of anchoring the stomach 10 to the diaphragm 110, creating a flap element of a flap valve at the opening of the esophagus into the stomach 36, and bringing the sealing surfaces closer together, i.e., shifting the tissue at the base of the flap in the direction of the opening of the opening of the esophagus into the stomach 36.

An advantage of involving tissue extrinsic to the stomach is the potential to limit the freedom of movement of at least the secured portion of the stomach relative to some other organ or tissue. The importance of this limitation of movement is well recognized in the surgical treatment of GERD. Hill L D 1989, J Thorac Cardiovasc Surg 98:1-10. The classic Hill gastropexy, an open procedure, includes anchoring the GEJ to the median arcuate ligament of the diaphragm, thereby eliminating or at least reducing the mobility of a sliding hiatus hernia.

As in other aspects of this invention, endoscopic visualization may be used for all or any part of the method.

In a preferred embodiment, the at least one tissue fixation device 24 makes a through-and-through penetration of the sequential full thicknesses of stomach 10, entrapped aspect of diaphragm 110, and stomach 10. In another embodiment, the at least one tissue fixation device 24 makes both a through-and-through penetration of the full thicknesses of one face of the stomach 10 and entrapped aspect of diaphragm 110, and a partial penetration of the opposing face of stomach 10. Fixation can alternatively be effected by (1) applying at least one tissue fixation device 24 through the full thickness of one face of the stomach 10 into at least a partial thickness of the entrapped aspect of the diaphragm 110, and (2) applying at least one tissue fixation device 101 through the full thickness of a second face of the stomach into at least a partial thickness of the entrapped aspect of the diaphragm 110. Similarly, combinations of full- and partial-thickness bilateral fixations can be employed.

According to another embodiment of this method of the invention, stomach 10 and an aspect of the extrinsic tissue structure 110 are brought into apposition through engagement and invagination of a portion of the inner aspect of stomach 10. Stomach 10 and extrinsic structure 110 are then fixed together by the application from the lumen 13 of the stomach of at least one tissue fixation device 24 to penetrate both the stomach and at least a partial thickness of the extrinsic tissue structure.

In yet another embodiment of this method of the invention, stomach 10 and extrinsic tissue structure 110 may already be naturally in desired apposition. In such applications there may be no need for the engaging and manipulating steps. The stomach and extrinsic structure are then fixed together by the application from lumen 13 of stomach 10 of at least one tissue fixation device 24 to penetrate both the stomach and at least a partial thickness of the extrinsic tissue structure.

D. Instruments and Devices for Endoscopically Reconfiguring Tissue Within a Hollow Organ

In another aspect this invention relates to novel instruments useful for reconfiguring tissue within a hollow organ in accordance with the methods of this invention. Such instruments may incorporate at least two of the following aspects: tissue engagement device; tissue manipulation device; tissue securing device; and viewing endoscope. In a preferred embodiment, described below, the invention provides a single instrument combining a tissue engaging device, tissue manipulation device, and tissue fixation device. A unique feature of this combination instrument is its ability to manipulate two or more points of tissue in any desired direction in three dimensional space.

An example of a preferred combination instrument 200 incorporating a tissue engagement device and a tissue manipulation device will now be discussed with reference to FIGS. 25, 26, 30, and 32-36.

Instrument 200 includes inner tube 280, concentric outer tube 290, a pair of opposable grasper arms 210, grasper arms yoke 220, a pair of independent small graspers 250, articulable stapler arms 230, stapler arms yoke 240, stapler cartridge 260 and stapler anvil 270. Instrument 200 may be constructed so that it can be sterilized by any method known in the art, e.g., steam autoclaving, gamma irradiation, and gas sterilization. Grasper arms 210 are attached to grasper yoke 220 which is in turn attached by articulable joint 222 to outer tube 290. Grasper arms 210 are thus able to open and close in order to grasp, as well as to pivot about 180° as a unit relative to the long axis of the instrument. A pair of torsion springs 216 cause the grasper arms 210 to tend to assume an open position in which ends 209 thereof are spaced, and the grasper yoke 220 to tend to assume an off-axis position. Stapler arms 230 are attached to stapler yoke 240 which is in turn attached by articulable joint 242 to inner tube 280. Stapler arms 230 are thus able to open and close and to pivot about 180° as a unit relative to the long axis of the instrument. A pair of torsion springs 236 cause the stapler arms 230 to tend to assume an open position in which cartridge 260 and anvil 270 are spaced from one another, and the stapler yoke assembly 240 to tend to assume an on-axis position. The long axis of the instrument is defined by the concentric axes of inner tube 280 and outer tube 290. Tubes 280 and 290 are constructed so that inner tube 280 can slide and rotate within outer tube 290, thus permitting grasper yoke 220 and stapler yoke 240 to move in relation to each other along and about the long axis of the instrument. Stapler cartridge 260 and stapler anvil 270 are disposed near the spaced, distal ends of respective stapler arms 230. Cartridge 260 and anvil 270 can be specially structured or structured according to conventional designs which are well known in the art.

A small grasper 250 is disposed at the end of each stapler arm 230. As illustrated in FIGS. 25 and 26, each small grasper 250 includes two opposed, toothed jaws pivotally mounted at one end. Small graspers 250 are constructed and activated by a small grasper cable assembly 254 in the same manner as commercially available endoscopic graspers, forceps, biopsy forceps that are well known in the art.

In a more preferred embodiment, either or both of small graspers 250 are substituted with a helical tissue engagement device 300 as depicted in FIG. 27. Helical device 300 has a shape much like a corkscrew and includes a distal effector end operably connected by a shaft to a proximal controlling end which remains outside the subject when in use. As shown in FIG. 27, the distal end of tissue engaging device 300 includes a generally helical spiral 304 having sharpened end 308 and being attached to a shaft 306 which is at least somewhat flexible along its length but sufficiently rigid to transmit a torque to spiral 304 to allow spiral 304 to be screwed into and out of tissue contacted by the sharpened end 308 of spiral 304. Spiral 304 having sharpened end 308 is structured to engage tissue when turned in one direction and to release tissue when turned in the opposite direction. Spiral 304 will typically be made of titanium, stainless steel, or like material suitable for surgical instrumentation with a wire diameter of about 0.015″-0.040″. In a preferred embodiment, spiral 304 wire diameter is 0.025″. Example dimensions for spiral 304 include radial outside diameter 0.080″-0.250″, and, in a preferred embodiment, 0.120″. Corkscrew-type tissue engaging device 300 is advanced through a working channel of an endoscopic instrument. Alternatively, corkscrew-type tissue engaging device 300 is slidably disposed within an overtube 302 so that the operator can cause sharpened end 308 of spiral 304 to protrude beyond and retract within the distal end of the overtube 302 by a desired amount. Overtube 302 may be made of stainless steel, extruded polymer with embedded stainless steel braid, polyethylene, polypropylene, polyimide, TEFLON, or similar suitable biocompatible material. In another alternative, corkscrew-type tissue engaging device 300 is advanced through a working channel of the combination instrument 200. Such a working channel is a hollow tube suitable to accommodate a remotely operated surgical tool such as corkscrew-type tissue engaging device 300, a needle, a grasper, a biopsy device, a brush, an electrocautery electrode, and the like.

In yet another embodiment, either or both of graspers 250 is substituted with suction devices as depicted in FIG. 28. “Suction” as used herein is equivalent to vacuum or reduced pressure, relative to ambient atmospheric pressure. In its simplest embodiment, shown in FIG. 28, the suction-based tissue engaging device 400 is an open-ended tube 402 with aperture 406 at its distal end 408, tube 402 constructed with sufficient axial rigidity to resist collapse under the force of an effective vacuum existent within its lumen 404 when applied end-on to tissue at distal end 408. In another embodiment shown in FIG. 28 the suction-based tissue engaging device 420 is a blind-ended tube 422 with at least one aperture 426 in a side wall near distal end 428, tube 422 having sufficient axial rigidity to resist collapse under the force of an effective vacuum existent within its lumen 404 when applied side-on to tissue. End or side apertures 406 or 426 can include a flange 412. FIG. 28 illustrates one such embodiment 430 in which aperture 406 at distal end 408 of open-ended tube 402 opens into flange 412 in fluid communication with lumen 404. Flange 412 can take the shape of a cone, cup, portion of a sphere, or otherwise smoothly concave surface. The source of vacuum or reduced pressure can be provided by operative connection at proximal end 410 to any means well known in the art, provided the vacuum supplied is effective for engaging tissue and suitable for the purposes of the invention. Such means include, without limitation, commercially available vacuum pumps, “wall suction” available in any hospital operating room and in many medical or surgical procedure rooms and many patient rooms at a hospital, side-arm aspirator, and the like. Reduced pressures suitable for the purposes of the invention typically fall between 10 and about 560 mm Hg but may vary with aperture size and shape.

For the purposes of the description which follows, graspers 250 are understood to be non-limiting, i.e., corkscrew-like retractors 300 or suction devices 400 can be used to similar effect.

As shown in FIG. 26, cable assembly 214 is coupled to grasper arms 210 and, together with grasper arms torsion springs 216 causes grasper arms 210 to open and close. Tensioning grasper arms cable assembly 214 counteracts grasper arms torsion springs 216 to cause grasper arms 210 to close; relaxing grasper arms cable assembly 214 permit grasper arms torsion springs 216 to cause the grasper arms 210 to open. Similarly, cable assembly 234 is coupled to stapler arms 230, and together with stapler arms torsion springs 236 cause to permit stapler arms 230 to open and close. Tensioning stapler arms cable assembly 234 counteracts stapler arm torsion springs 236 to cause stapler arms 230 to close; relaxing stapler arms cable assembly 234 permits stapler arms torsion springs 236 to cause stapler arms 230 to open.

Stapler cartridge 260 is disposed on the end of one stapler arm 230 and is activated by cable assembly 264 to deploy at least one staple into tissue. Stapler anvil 270 disposed on the distal end of the other stapler arm 230 and stapler cartridge 260 are brought into apposition by tensioning stapler arms cable assembly 234.

In an alternative embodiment, stapler cartridge 260 and stapler anvil 270 are substituted with corresponding elements structured to deliver at least one two-part fastener as described above. An example of a preferred embodiment of a two-part fastener is shown in FIG. 29. The fastener includes a first part 350 and a second part 360. First part 350 includes a head 352 and a post 354 having a conical end which tapers to a point 356 capable of piercing tissue. Second part 360 is an annular retainer 362 structured to engage post 354 with retainer slotted flange 364 when point 356 is advanced through retainer aperture 366. Slotted flange 364 includes a plurality of rigid radially extending flaps which also extend axially away from head 352 on one side of aperture 366. Flaps of slotted flange 364 allow post 354 to be inserted through aperture 366 from the other side of aperture 366, but prevent withdrawal of post 354 once inserted. Flaps of slotted flange 364 bend radially outwardly to accommodate post 354, the diameter of which otherwise exceeds the aperture 366, thus causing slotted flange 364 to engage and retain post 354. The length of post 354 is sufficient to penetrate through the desired amount or depth of tissue and to permit engagement by retainer 362 for the application for which it is used. Typically, such length will be ca. 0.25 inches. In a preferred embodiment the greatest outside diameter of head 352 or retainer 362 is ca. 0.250 inches. Post 354 can be grooved or threaded, e.g., with an 0-80 thread to provide a more secure engagement with slotted flange 364. Parts 350 and 360 preferably are made of titanium, stainless steel, biocompatible polymer, or a combination of such materials. For the purposes of the description which follows, stapler cartridge 260 and stapler anvil 270 are understood to be non-limiting, i.e., elements structured to deliver at least one two-part fastener could be used to similar effect.

As shown in FIG. 30, grasper arms yoke cable assembly 224 and grasper arms yoke torsion spring 228 are coupled to grasper arms yoke 220. Grasper arms yoke 220 and grasper arms 210 pivot about articulable joint 222. Tensioning of grasper arms yoke cable assembly 224 counteracts the grasper arms yoke torsion spring 228 to cause the grasper arms yoke 220 to pivot so that the free ends 209 of grasper arms 210 pivot away from stapler arms yoke 240; relaxing of grasper arms yoke cable assembly 224 permits grasper arms yoke torsion spring 228 to cause the grasper arms yoke 220 to pivot so that the free ends 209 of grasper arms 210 pivot toward the stapler arms yoke 240.

Similarly, stapler arms yoke cable assembly 244 and stapler arms yoke torsion spring 248 are coupled to stapler arms yoke 240. Yoke 240 pivots about an articulable joint 242. Tensioning of stapler arms yoke cable assembly 244 counteracts stapler arms yoke torsion spring 248 to cause the stapler arms yoke 240 to pivot so that the free ends of stapler arms 230 pivot toward grasper arms yoke 220; relaxing of stapler arms yoke cable assembly 244 permits stapler arms yoke torsion spring 248 to cause stapler arms yoke 240 to pivot so that the free ends of grasper arms 230 pivot away from grasper arms yoke 220.

An optional feature of instrument 200 shown in FIG. 31 is the inclusion of at least one of pressure monitoring tubes 500 and 520. Tube 500 includes at least one opening 506 positioned in the vicinity of the grasper arms yoke 220 and permits measurement of tissue pressure at the GEJ when instrument 200 is advanced into position as previously described. The proximal end of tube 500 is operably connected to a manometer outside the subject. Tube 520 includes at least one opening 506 positioned anywhere along stapler arms 230 and permits measurement of yield pressure when instrument 200 is advanced into position as previously described. The proximal end of tube 520 is operably connected to a manometer outside the subject. Tubes 500 and 520 are preferably made of a biocompatible polymer and are structured to have an inside diameter of at least ca. 0.020 inches. Tube 500 terminates as a blind-ended tube at its distal end 504 and has an opening 506 in its side wall near distal end 504. Tube 520 may also terminate as a blind-ended tube at its distal end 504 and has an opening 506 in its side wall near distal end 524. Alternatively, tube 520 may terminate as an open-ended tube at distal end 524.

Measurement of the tissue pressure at the GEJ, the yield pressure, or both pressures assists the operator in determining where to engage, manipulate, and/or secure tissue to greatest advantage. Pressure measurements can be taken at any point throughout the procedure. For example, an operator performing any of the described methods for treating GERD can take a baseline measurement of at least one of these pressures, engage and manipulate tissue, take another measurement, disengage tissue, and then repeat at least the steps of engaging, manipulating, and measuring, until a desired pressure is obtained. Likewise, an operator performing any of the described methods for treating GERD can take a baseline measurement of at least one of these pressures, engage and manipulate tissue, take another measurement, disengage tissue, and then repeat at least the steps of engaging, manipulating, and measuring, to determine an optimal location of engagement, an optimal manipulation, and/or an optimal point of fixation.

When instrument 200 is used for the methods of this invention, the distal end of instrument 200, including stapler arms 230, stapler arms yoke 240, grasper arms yoke 220, and grasper arms 210, is introduced into stomach 10 of a subject via a conduit which may be esophagus 12 or a gastrostomy. During the introduction of the instrument into the stomach, the instrument is positioned as shown in FIG. 25. When positioned as shown in FIG. 25, the entire distal end of instrument 200 is structured to pass through a hole less than about one inch in diameter, and more preferably, through a hole no more than 2.0 cm in diameter. Next, stapler arms yoke 240 is rotated by tensioning stapler arms yoke cable assembly 244, stapler arms 230 are opened by relaxing stapler arms cable assembly 234, and inner tube 280 is 20 advanced within outer tube 290. The instrument thus assumes the configuration shown in FIG. 32.

The two small graspers 250 engage tissue at two independent points. Tissue so engaged can be manipulated simply by tensioning stapler arms cable assembly 234, to bring the two small graspers 250 into closer proximity. Such manipulation can be used to create a mound of tissue by effectively squeezing tissue interposed between the two small graspers 250. Such an operation may be useful in bringing sealing surfaces closer together to tighten an existing flap valve, such as in FIGS. 15 and 17. In FIG. 15, small graspers 250 engage tissue at points 73 and 75 and stapler arms 230 are brought into closer approximation by tensioning stapler arms cable assembly 234 to create a mound of tissue 72 adjacent to the existing flap valve 70. At least one staple is deployed by stapler cartridge 260 into the tissue at location 77 to stabilize the tissue reconfiguration. Similarly in FIG. 17, small graspers 250 engage tissue at first pair of points 89 and 91 (or 85 and 87) and stapler arms 230 are brought into closer approximation by tensioning stapler arms cable assembly 234 to bring points 89 and 91 (or 85 and 87) into closer approximation. At least one staple is deployed by cartridge 260 into the tissue at respective location 93 (or 95) to stabilize the tissue reconfiguration. These steps are then repeated with respect to the other pair of points.

The two small graspers 250 can evaginate tissue by sliding the stapler arms yoke 240 in the direction of the desired evagination, such as shown in FIG. 17. Grasper arms 86 correspond to stapler arms 230; associated small graspers 82 to small graspers 250; and stapler elements 84 to stapler cartridge 260 and stapler anvil 270.

Small graspers 250 also may be used to advantage in combination with grasper arms 210. After introduction of the distal end of instrument 200 into the lumen of the stomach and assumption of configuration shown in FIG. 32 as above, FIG. 33 shows small graspers 250 and grasper arms 210 are opened and ready to be brought into contact with tissue. Following tissue contact, FIG. 34 shows grasper arms 210 closed to engage tissue near opening of esophagus into stomach 36, while small graspers 250 are closed to engage tissue at points that will be moved to create a plication, as shown in FIG. 22. As shown in FIG. 35, tissue so engaged can be manipulated by any combination of pivoting grasper arms 210, pivoting stapler arms 230, and positioning grasper arms yoke 220 relative to stapler arms yoke 240. In a preferred embodiment, stapler arms 230 are closed and stapler arms yoke 240 is pivoted as required to bring tissue together around the distal esophagus, creating a plication, as shown in FIG. 36.

Another embodiment of a tissue engaging and manipulating device 600 is illustrated with respect to FIG. 37. Device 600 includes a conventional endoscope 602 onto which or in conjunction with which a roller assembly 604 is mounted. Roller assembly 604 includes a pair of rollers 606 and 607 which are each independently journalled for free rotation on a pair of support arms 608. Support arms 608 in turn are fixed to support structure 610 which is coupled to endoscope 602. Each roller 606 and 607 includes teeth 612. Teeth 612 of one roller 606 preferably interengage teeth 612 of the other roller 607. However, in an alternative embodiment, the ends of teeth 612 on each roller 606 and 607 could be spaced a very small distance from one another. Preferably, teeth 612 extend from rollers 606 and 607 at an angle with respect to a radius of rollers 606. However, teeth 612 could extend radially. Rollers 606 and 607 rotate in opposite directions from one another. In other words, while roller 606 would rotate in a clockwise direction as shown in FIG. 37, roller 607 would rotate in a counter-clockwise direction, as shown in FIG. 37. In this way, tissue engaged by rollers 606 and 607 would be captured and drawn between rollers 606 and 607 to form a flap, bulge, mound or the like. Preferably, the direction of rotation of rollers 606 and 607 could be reversed to release tissue once fixation of the tissue had been obtained. Alternatively, support structure 610 can be structured so as to permit rollers 606 and 607 to disengage by swinging apart from one another. At least one of rollers 606 and 607 is driven by an externally disposed hand-operated mechanism or servo motor (not shown) which is coupled to each driven roller 606 and/or 607 by a suitable cable (not shown).

In operation, the combined endoscope and device 600 is deployed endoscopically into a subject's stomach. Utilizing viewing endoscope 602, device 604 is positioned to engage tissue at a desirable location within the stomach or other organ. Once placed in the desired location, the hand-operated mechanism or servo motor (not shown) is activated to rotate rollers 606 and 607 to engage and manipulate the tissue to a desired size and shape. Thereafter, rotation of rollers 606 and 607 is discontinued. A suitable fixation device (not shown) is deployed endoscopically to fix the resulting reconfigured tissue in its reconfigured shape. The tissue fixation device utilized is one of those previously described with respect to this invention, including a conventional stapler. Upon completion of the fixation step, the directions of rotation of rollers 606 and 607 are reversed to release the tissue from rollers 606 and 607. Thereafter, device 600 may be moved to a different location within the stomach or other organ and the steps described above may be repeated.

Since the device of the present invention is novel and it is intended to be used in treating a human subject, it is important that the physician operator be instructed to use the device mechanisms and methods disclosed herein. The training of the device and method may be accomplished on a cadaver or a human model, or it may be accomplished at the bedside of a patient.

Equivalents

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.

Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US34708756 Oct 19667 Oct 1969Johnson Alfred ASurgical clamping and suturing instrument
US355198712 Sep 19685 Ene 1971Wilkinson Jack EStapling clamp for gastrointestinal surgery
US363865331 Jul 19691 Feb 1972Berry H LeeSuturing device
US38428407 May 197322 Oct 1974Schweizer ESuture applicator
US390124414 Jun 197426 Ago 1975Schweizer Edward ESuture cartridge
US394674015 Oct 197430 Mar 1976Bassett John WSuturing device
US400674723 Abr 19758 Feb 1977Ethicon, Inc.Surgical method
US416422528 Dic 197714 Ago 1979Johnson & Lorenz, Inc.Surgical suturing instrument
US42352384 May 197925 Nov 1980Olympus Optical Co., Ltd.Apparatus for suturing coeliac tissues
US44481943 Feb 198215 May 1984Ethicon, Inc.Full stroke compelling mechanism for surgical instrument with drum drive
US44717813 Feb 198218 Sep 1984Ethicon, Inc.Surgical instrument with rotatable front housing and latch mechanism
US45000249 Jun 198319 Feb 1985Ethicon, Inc.Multiple clip applier
US450667030 Mar 198326 Mar 1985United States Surgical CorporationTwo-part surgical fastener applying apparatus with frangible member
US457346920 Jun 19834 Mar 1986Ethicon, Inc.Two-piece tissue fastener with coinable leg staple and retaining receiver and method and instrument for applying same
US458515316 Jul 198429 Abr 1986Ethicon, Inc.Builder, chlorine bleach, alkyl phosphate, nonionic surfactant
US458650231 Jul 19846 May 1986Ethicon, Inc.Surgical instrument actuator with non-collinear hydraulic pistons
US459108516 Jul 198427 May 1986Ethicon, Inc.Surgical instrument for applying fasteners, said instrument having an improved trigger interlocking mechanism (Case VI)
US460500416 Jul 198412 Ago 1986Ethicon, Inc.Surgical instrument for applying fasteners said instrument including force supporting means (case IV)
US460634516 Jul 198419 Ago 1986Ethicon, Inc.Surgical instrument for applying two-piece fasteners comprising U-shaped staples and frictionally held receivers (Case II)
US46274375 Jun 19859 Dic 1986Ethicon, Inc.Method of applying a fastener to tissue with a pair of hollow needles
US47248403 Feb 198216 Feb 1988Ethicon, Inc.Surgical fastener applier with rotatable front housing and laterally extending curved needle for guiding a flexible pusher
US473674617 Nov 198612 Abr 1988Dennison Manufacturing CompanyMethod of fastening tissues
US474133612 Mar 19863 May 1988Ethicon, Inc.Shaped staples and slotted receivers (case VII)
US488761227 Abr 198819 Dic 1989Esco Precision, Inc.Endoscopic biopsy forceps
US48906155 Nov 19872 Ene 1990Concept, Inc.Arthroscopic suturing instrument
US493502721 Ago 198919 Jun 1990Inbae YoonSurgical suture instrument with remotely controllable suture material advancement
US503743317 May 19906 Ago 1991Wilk Peter JEndoscopic suturing device and related method and suture
US50889792 Nov 199018 Feb 1992Wilson-Cook Medical Inc.Method for esophageal invagination and devices useful therein
US51473731 Nov 199115 Sep 1992Ferzli George SLaparoscopic instrument
US522296317 Ene 199129 Jun 1993Ethicon, Inc.Absorbable anastomotic tissue fastener
US525412624 Jun 199219 Oct 1993Ethicon, Inc.Endoscopic suture punch
US534650419 Nov 199213 Sep 1994Ethicon, Inc.Intraluminal manipulator with a head having articulating links
US535641619 Oct 199318 Oct 1994Boston Scientific CorporationCombined multiple ligating band dispenser and sclerotherapy needle instrument
US535850815 Sep 199325 Oct 1994Eric CobbLaparoscopic device
US53644084 Sep 199215 Nov 1994Laurus Medical CorporationEndoscopic suture system
US53950302 Jun 19937 Mar 1995Olympus Optical Co., Ltd.Surgical device for stapling and fastening body tissues
US54033261 Feb 19934 Abr 1995The Regents Of The University Of CaliforniaMethod for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux
US543372115 Jul 199318 Jul 1995Ethicon, Inc.Endoscopic instrument having a torsionally stiff drive shaft for applying fasteners to tissue
US544150711 Abr 199415 Ago 1995Wilk; Peter J.Laparoscopic or endoscopic anastomosis technique and associated instruments
US54475122 Nov 19935 Sep 1995Boston Scientific CorporationController for intracorporeal knot tying apparatus
US54658946 Dic 199314 Nov 1995Ethicon, Inc.Surgical stapling instrument with articulated stapling head assembly on rotatable and flexible support shaft
US548618922 Oct 199323 Ene 1996United States Surgical CorporationEndoscopic surgical instrument
US549633127 Jul 19945 Mar 1996Terumo Kabushiki KaishaKnot-forming instrument and method of forming knots
US55228209 Nov 19944 Jun 1996ArthrotechMethod and apparatus for suturing tissue
US554961821 Feb 199527 Ago 1996Coral MedicalAssembly for use in surgery
US555866524 Jun 199424 Sep 1996Archimedes Surgical, Inc.Surgical instrument and method for intraluminal retraction of an anatomic structure
US55710907 Oct 19945 Nov 1996United States Surgical CorporationVascular suturing apparatus
US55711162 Oct 19945 Nov 1996United States Surgical CorporationSurgical stapler
US55734967 Jun 199512 Nov 1996Mcpherson; William E.Method of using a coil screw surgical retractor
US562445330 Oct 199529 Abr 1997Wilson-Cook Medical, Inc.Endoscopic ligating instrument
US56266134 May 19956 May 1997Arthrex, Inc.Corkscrew suture anchor and driver
US566268322 Ago 19952 Sep 1997Ortho Helix LimitedOpen helical organic tissue anchor and method of facilitating healing
US56650967 Mar 19959 Sep 1997Yoon; InbaeFor suturing anatomical tissue
US56766744 Nov 199614 Oct 1997Bolanos; HenrySurgical stapler
US569794014 Oct 199416 Dic 1997Boston Scientific CorporationMultiple ligating band dispenser
US572242115 Sep 19953 Mar 1998Symbiosis CorporationClevis having deflection limiting stops for use in an endoscopic biopsy forceps instrument
US57255243 Ene 199610 Mar 1998Medtronic, Inc.Apparatus for R-F ablation
US57281098 Abr 199717 Mar 1998Ethicon Endo-Surgery, Inc.Surgical knot and method for its formation
US57358616 Sep 19957 Abr 1998Wilson-Cook Medical, Inc.To ligate lesions within a hollow body organ
US574128013 Nov 199521 Abr 1998Coral MedicalKnot tying method and apparatus
US57498988 Abr 199712 May 1998Ethicon Endo-Surgery, Inc.Suture cartridge assembly for a surgical knot
US578789728 Feb 19964 Ago 1998Archimedes Surgical, Inc.Surgical method for intraluminally plicating a fundus of a patient
US579215323 Mar 199511 Ago 1998University College LondonFor passing a thread through a tissue substrate portion
US579792722 Sep 199525 Ago 1998Yoon; InbaeCombined tissue clamping and suturing instrument
US581088220 Dic 199622 Sep 1998Origin Medsystems, Inc.Surgical helical fastener with applicator and method of use
US581405423 Sep 199629 Sep 1998Symbiosis CorporationAutomatic needle-passer suturing instrument
US58267762 Oct 199627 Oct 1998Ethicon Endo-Surgery, Inc.Surgical instrument
US58462549 Oct 19978 Dic 1998Ethicon Endo-Surgery, Inc.Surgical instrument for forming a knot
US585340927 Ene 199729 Dic 1998E.P. Technologies, Inc.Systems and apparatus for sensing temperature in body tissue
US58553117 Jun 19955 Ene 1999Ethicon Endo-SurgeryReloadable surgical instrument
US588759422 Sep 199730 Mar 1999Beth Israel Deaconess Medical Center Inc.Methods and devices for gastroesophageal reflux reduction
US58935928 Abr 199713 Abr 1999Ethicon Endo-Surgery, Inc.Partially tied surgical knot
US58975628 Oct 199727 Abr 1999United States Surgical CorporationNon-invasive apparatus for treatment of gastroesophageal reflux disease
US59018954 Oct 199611 May 1999United States Surgical CorporationArticulating apparatus for applying surgical fasteners to body tissue
US599346617 Jun 199730 Nov 1999Yoon; InbaeSuturing instrument with multiple rotatably mounted spreadable needle holders
US600987719 Feb 19984 Ene 2000Edwards; Stuart D.Method for treating a sphincter
US605100312 Nov 199718 Abr 2000Boston Scientific CorporationCombined multiple ligating band dispenser and sclerotherapy needle instrument
US605979823 Dic 19989 May 2000Boston Scientific CorporationDistal end for ligating band dispenser
US606799029 May 199830 May 2000Surgical, Inc.Method for esophageal retraction
US60866003 Nov 199711 Jul 2000Symbiosis CorporationFlexible endoscopic surgical instrument for invagination and fundoplication
US611360926 May 19985 Sep 2000Scimed Life Systems, Inc.Implantable tissue fastener and system for treating gastroesophageal reflux disease
US615914612 Abr 199912 Dic 2000El Gazayerli; Mohamed MounirMethod and apparatus for minimally-invasive fundoplication
US617984023 Jul 199930 Ene 2001Ethicon, Inc.Graft fixation device and method
US622108415 Ene 199924 Abr 2001Pare Surgical, Inc.Knot tying apparatus having a notched thread cover and method for using same
US635250315 Jul 19995 Mar 2002Olympus Optical Co., Ltd.Endoscopic surgery apparatus
US638710412 Nov 199914 May 2002Scimed Life Systems, Inc.Method and apparatus for endoscopic repair of the lower esophageal sphincter
EP0480428A210 Oct 199115 Abr 1992Wilson-Cook Medical Inc.Device for esophageal invagination
EP0576265A223 Jun 199329 Dic 1993Ethicon Inc.Endoscopic suture punch
EP0646356A229 Sep 19945 Abr 1995Ethicon Inc.Articulable socket joint assembly for an endoscopic instrument and surgical fastener track therefor
FR2768324A1 Título no disponible
WO1999022649A22 Nov 199814 May 1999Symbiosis CorpFlexible endoscopic instrument for invagination and fundoplication
WO2000078229A121 Jun 200028 Dic 2000Michael D LauferDevice and method for correction of a painful body defect
WO2002024080A224 Sep 200128 Mar 2002Scimed Life Systems IncMethods and devices for folding and securing tissue
Otras citas
Referencia
1Boerema, M.D., "Hiatus hernia: Repair by right-sided, subhepatic, anterior gastropexy," Surgery, 65:884-893 (1969).
2Carvalho PJPC et al., PJPC et al., Fibrosis of gastric cardia after endoscopic sclerosis. Mechanism for control of experimental reflux? Am Surg Mar. 1990;56(3):163-6.
3Cecconello, "Esophagogastric Anastomosis with Valvuloplasty: An Experimental Study," International Surgery, 67:121-124 (1982).
4Collis, M.D., "An Operation for Hiatus Hernia with Short Esophagus," The Journal of Thoracic Surgery, 34:768-778 (1957).
5Collis, M.D., "Surgical Control of Reflux in Hiatus Hernia," The American Journal of Surgery, 115:465-471 (1968).
6Contractor QQ et al., Endoscopic esophagitis and gastroesophageal flap valve. J Clin Gastroenterol Apr. 1999;28(3):233-7.
7Cuschieri, et al., "Multicenter prospective evalauation of laparoscopic antireflux surgery," Surgical Endoscopy, 7:505-510 (1993).
8DeMeester, M.D. et al., "Nissen Fundoplication for Gastroesophageal Reflux Disease," Annals of Surgery, 204:9-20 (1986).
9Donahue PE et al., Endoscopic sclerosis of the gastric cardia for prevention of experimental gastroesophageal reflux. Gastrointest Endosc May-Jun. 1990;36(3):253-6.
10Donahue, M.D., et al., "Endoscopic Control of Gastro-Esophageal Reflux: Status Report," World Journal of Surgery, 16:343-346 (1992).
11Donahue, M.D., et al., "Endoscopic sclerosis of the gastic cardia for prevention of experimental gastroesophageal reflux," Gastrointestinal Endoscopy, 36:253-256 (1990).
12Donahur PE et al., Endoscopic control of gastro-esophageal reflux: status report. World J Surg Mar.-Apr. 1992;16(2):343-6.
13Falk, et al., "Laparoscopic Fundoplication: A preliminary report of the technique and postoperative care," Aust. N.Z. J. Surgery, 62:969-972 (1992).
14Hill LD and Kozarek RA, The gastroesophageal flap valve. J Clin Gastroenterol Apr. 1999;28(3):194-7.
15Hill LD et al., Antireflux surgery. A surgeon's look. Gastroenterol Clin North Am Sep. 1990;19(3):745-75.
16Hill LD et al., The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc Nov. 1996;44(5):541-7.
17Hill LD, Intraoperative measurement of lower esophageal sphincter pressure. J Thorac Cardiovasc Surg Mar. 1978;75(3):378-82.
18Hill LD, Myths of the esophagus. J Thorac Cardiovasc Surg Jul. 1989;98(1):1-10.
19Hill, et al., "Surgery for Peptic Esophageal Stricture, " 139-147.
20Hill, et al., "The Esophagus, Medical and Surgicial Management," WB Saunders Co., 135-8 (1988).
21Hill, M.D. "An Effective Operation for Hiatal Hernia: An Eight Year Appraisal," Annals of Surgery, 166:681-692 (1967).
22Hinder, et al. "The Surgical Option for Gastroesophageal Reflux Disease," Symposium on Gastroesophageal Reflux Disease, Am J Med, 103:144S-148S (1997).
23Ismail T et al., Yield pressure, anatomy of the cardia and gastro-oesophageal reflux, Br J Surg Jul. 1995;82(7):943-7.
24Ismail, et al., "Yield Pressure: A New Concept in the Evaluation of Gerd?," AJG, 91:616-617 (1996).
25Jamieson, et al. ,"The development of surgery for gastro-oesophageal reflux disease," Surgery of the Oesaphagus, 233-245 (1988).
26Jamieson, et al., "Laparoscopic Nissen Fundoplication,"Annals of Surgery, 220:137-145 (1994).
27Janssen, et al., "Prospective randomized comparison of teres cardiopexy and Nissen fundoplication in the surgical therapy of gastro-oesophageal reflux disease," Br. J. Surg. 80:875-878 (1993).
28Jennings RW et al., A novel endoscopic transgastric fundoplication procedure for gastroesophageal reflux: an initial animal evaluation. J Laparoendosc Surg Oct. 1992;2(5):207-13.
29Jennings, et al., "A Novel Endoscopic Transgastric Fundoplication Procedure for Gastroesophageal Reflux: An Initial Animal Evaluation," Journal of Laparoendoscopic Surgery, 2:207-213 (1992).
30Kadirkamanathan SS et al., An ambulant procine model of acid reflux used to evaluate endoscopic gastroplasty. Gut Jun. 1999;44(6):782-8.
31Kadirkamanathan SS et al., Antireflux operations at flexible endoscopy using endoluminal stitching techniques: an experimental study. Gastrointest Endosc Aug. 1996;44(2):133-43.
32Kahrilas, "Gastroesophageal Reflux Disease,"JAMA, 276:983-988 (1996).
33Kraemer, M.D., et al., "Laparoscopic Hill repair," Gastrointestinal Endoscopy, 40:155-159 (1994).
34Little, M.D., "Mechanisms of Action of Antireflux Surgery: Theory and Fact," World Journal of Surgery, 16:320-325 (1992).
35Mason RJ et al., A new intraluminal antigastroesophageal reflux procedure in baboons. Gastrointest Endosc Mar. 1997;45(3):283-90.
36Mason, et al., "Nissen Fundoplication Prevents Shortening of the Sphincter During Gastric Distention," ARCH SURG., 132:719-726 (1997).
37McGouran RC and Galloway JM, A laser-induced scar at the cardia increases the yield pressure of the lower esophageal sphincter. Gastrointest Endosc Sep.-Oct.;36(5):439-43.
38McGouran RC et al., Does measurement of yield pressure at the cardia during endoscopy provide information on the function of the lower oesophageal sphincter mechanism? Gut Mar. 1988;29(3):275-8.
39McGouran RC et al., Is yield pressure at the cardia increased by effective fundoplication? Gut Oct. 1998;30(10):1309-12.
40McGouran, M.D., et al., "A laser-induced scar at the cardia increases the yield pressure of the lower esophageal sphincter," Gastronintestinal Endoscopy, 36:439-443 (1990).
41McKernan, "Laparoscopic repair of gastroesophageal reflux disease," Surgical Endoscopy, 8:851-856 (1994).
42Nathanson, et al., "Laparoscopic Ligamentum teres (round ligament) cardiopexy," Br. J. Surg., 78:947-951 (1991).
43Nissen, "Eine einfache Operation zur Beeinflussung der Refluxoesophagitis," Journal Suisee De Medecine, 590-592 (1956).
44O'Connor KW and Lehman GA, Endoscopic placement of collagen at the lower esophageal sphincter to inhibit gastroesophageal reflux: a pilot study of 10 medically intractable patients. Gastrointest Endosc Mar.-Apr. 1988;34(2):106-12.
45O'Connor KW et al., An experimental endoscopic technique for reversing gastroesophageal reflux in dogs by injecting inert material in the distal esophagus. Gastrointest Endosc Oct. 1984;30(5):275-80.
46O'Connor, et al., "Endoscopic placement of collagen at the lower esophageal sphincter to inhibit gastroesophageal reflux: a pilot study of 10 medically intractable patients," Gastrointestinal Endoscopy, 34:106-112 (1988).
47Polk, et al. "Hiatol Hernia and Esophagitis: A survey of indications for operation and technic and results of fundoplication," Ann. Surg., 173:775-781 (1971).
48Rich, "Simple GERD Treatment Offers New Alternative,"(www.medicalpost.com website), Mar. 1999.
49Rupp TH and Lehman GA, Endoscopic antireflux techniques, Endoluminal and laparoscopic. Gastrointest Endosc Clin N Am Apr. 1994;4(2):353-68.
50Shafik A, Intraesophageal Polytef injection for the treatment of reflux esophagitis. Surg Endosc Mar. 1996;10(3):329-31.
51Singh, et al., "Evaluation of the Endoscopic Suturing System in the Treatment of GERD," DDW, May 16-19, 1999.
52Skinner et al., "Surgical management of esophageal reflux and hiatus hernia," Journal of Thoracic and Cardiovascular Surgery, 53:33-54 (1967).
53Slim K et al., Intraoperative esophageal manometry and fundoplications: prospective study, World J Surg Jan. 1996;20(1):55-9.
54Starling, et al. Assessment of the Angelchik Prosthesis for Treatment of Symptomatic Esophageal Reflux, World J. Surg. 11, 350-355 (1987).
55Thor KBA et al., Reappraisal of the flap valve mechanism in the gastroesophageal junction. A study of a new valvuloplasty procedure in cadavers.Acta Chir Scand Jan. 1987;153(1):25-8.
56Tocornal, M.D., et al., "A mucosol flap valve mechanism to prevent gastroesophageal reflux and esophagitis," Surgery, 64:519-523 (1968).
57Wang, et al., "A new anti-flux procedure: cardiac oblique invagination," Chung Hua Wai Ko Tsa Chic, Feb; 33 (2) 73-5 (1995). (English Abstract).
58Watson, et al., "Comparison of anterior, posterior and total fundoplication using a viscera model," Diseases of the Esophagus, 10: 110-114 (1997).
59Westbrook, et al., "Posterior Surgical Approaches to the Rectum," Annals of Surgery, 195:677-691 (1982).
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US6845776 *8 Abr 200225 Ene 2005Richard S. StackSatiation devices and methods
US6872214 *2 Ago 200129 Mar 2005Medigus Ltd.Stapler for endoscopes
US6960233 *9 Dic 20031 Nov 2005Torax Medical, Inc.Methods and apparatus for improving the function of biological passages
US696691920 Sep 200222 Nov 2005Id, LlcInstrument for applying a surgical fastener particularly for the transoral treatment of gastroesophageal reflux disease (GERD)
US6986737 *3 Ene 200317 Ene 2006Olympus Optical Co., Ltd.Endoscopic method for forming an artificial valve
US69889853 Ene 200324 Ene 2006Olympus Optical Co., Ltd.Tissue piercing device for an endoscope
US703337820 Sep 200225 Abr 2006Id, LlcSurgical fastener, particularly for the endoluminal treatment of gastroesophageal reflux disease (GERD)
US7059331 *19 Sep 200213 Jun 2006Boston Scientific Scimed, Inc.Method and device for full thickness resectioning of an organ
US7074229 *9 Feb 200411 Jul 2006Scimed Life Systems, Inc.Device for performing endoluminal fundoplication
US71116279 Jun 200326 Sep 2006Synecor, LlcSatiation devices and methods
US71212834 Mar 200417 Oct 2006Synecor, LlcSatiation devices and methods
US7131978 *19 May 20037 Nov 2006Dvl Acquisition Sub, Inc.Surgical suturing instrument and method of use
US714698412 Mar 200312 Dic 2006Synecor, LlcMethod and apparatus for modifying the exit orifice of a satiation pouch
US7152607 *4 Mar 200426 Dic 2006Synecor, L.L.C.Satiation devices and methods
US71568573 Abr 20022 Ene 2007Olympus Optical Co., Ltd.Endoscopic instruments
US715686315 Mar 20012 Ene 2007Medigus Ltd.Fundoplication apparatus and method
US7204842 *21 Abr 200317 Abr 2007Boston Scientific Scimed, Inc.Devices and related methods for securing a tissue fold
US7288101 *14 Ene 200330 Oct 2007Satiety, Inc.Obesity treatment tools and methods
US73066133 Abr 200211 Dic 2007Olympus Optical Co., Ltd.Endoscopic instruments
US731880224 Nov 200415 Ene 2008Olympus Optical Co., Ltd.Endoscope and endoscopic suturing instrument for treatment of gastroesophageal reflux disease
US7344493 *31 Dic 200118 Mar 2008Medigus Ltd.Endoscopic device having ultrasonic positioning
US735445416 Jul 20048 Abr 2008Synecor, LlcSatiation devices and methods
US745236330 Sep 200318 Nov 2008Ethicon Endo-Surgery, Inc.Applier for fastener for single lumen access anastomosis
US7481225 *26 Ene 200527 Ene 2009Ethicon Endo-Surgery, Inc.Medical instrument including an end effector having a medical-treatment electrode
US75208847 May 200421 Abr 2009Usgi Medical Inc.Methods for performing gastroplasty
US76085789 Ago 200127 Oct 2009Temple University - Of The Commonwealth System Of Higher EducationInjecting a biocompatible bulking material such as collagen, elastin or fibrin submucosally or intramuscularly into pyloric area of the stomach to cause the lumen of pylorus to narrow and slow gastric emptying
US761500430 Mar 200610 Nov 2009Ethicon Endo-Surgery, Inc.Endoscopic ancillary attachment devices
US761506013 Jun 200510 Nov 2009Ethicon-Endo Surgery, Inc.Endoscopic suturing device
US761506426 Jul 200710 Nov 2009J.n Tailor Surgical, Inc.Endolumenal gastric ring with suspended impeding member
US762879631 Mar 20068 Dic 2009Ethicon Endo-Surgery, Inc.Surgical suturing apparatus with anti-backup system
US76288212 Ago 20058 Dic 2009Barosense, Inc.Obesity treatment method
US763228723 Sep 200415 Dic 2009Endogastric Solutions, Inc.Tissue fixation devices and assemblies for deploying the same
US763537325 May 200622 Dic 2009Ethicon Endo-Surgery, Inc.Absorbable gastric restriction devices and methods
US763790515 Ene 200329 Dic 2009Usgi Medical, Inc.Endoluminal tool deployment system
US765101723 Nov 200526 Ene 2010Ethicon Endo-Surgery, Inc.Surgical stapler with a bendable end effector
US7666195 *9 Sep 200323 Feb 2010Brian KelleherDevice and method for endoluminal therapy
US76742755 Oct 20069 Mar 2010Ethicon Endo-Surgery, Inc.Suture anchor
US767812220 Sep 200216 Mar 2010Id, LlcMethod of performing a treatment for gastroesophagheal reflux disease (GERD)
US768683131 Mar 200630 Mar 2010Ethicon Endo-Surgery, Inc.Method for securing a suture
US77226284 Abr 200725 May 2010Ethicon Endo-Surgery, Inc.Device for plicating and fastening gastric tissue
US7727249 *13 Jun 20071 Jun 2010Indiana University Research & Technology CorporationMethods and apparatuses for reshaping the esophagus and other body lumens
US773710929 Abr 200315 Jun 2010Temple University Of The Commonwealth System Of Higher EducationObesity controlling method
US774064620 Sep 200622 Jun 2010Ethicon Endo-Surgery, Inc.Adhesives for use with suture system minimize tissue erosion
US7749235 *20 Oct 20066 Jul 2010Ethicon Endo-Surgery, Inc.Stomach invagination method and apparatus
US775859819 May 200620 Jul 2010Ethicon Endo-Surgery, Inc.Combination knotting element and suture anchor applicator
US776303631 Mar 200627 Jul 2010Ethicon Endo-Surgery, Inc.Endoscopic instrument with secondary vacuum source
US776692531 Mar 20063 Ago 2010Ethicon Endo-Surgery, Inc.Surgical suturing apparatus
US777144018 Ago 200510 Ago 2010Ethicon Endo-Surgery, Inc.Method and apparatus for endoscopically performing gastric reduction surgery in a single pass
US7776053 *12 Dic 200617 Ago 2010Boston Scientific Scimed, Inc.Implantable valve system
US77798455 Ago 200524 Ago 2010Ethicon Endo-Surgery, Inc.Method and apparatus for endoscopically performing gastric reduction surgery
US77989924 Nov 200521 Sep 2010Ethicon Endo-Surgery, Inc.Lumen traversing device
US77990404 Abr 200721 Sep 2010Ethicon Endo-Surgery, Inc.Device for plicating and fastening gastric tissue
US78031654 Abr 200728 Sep 2010Ethicon Endo-Surgery, Inc.Device for plicating and fastening gastric tissue
US78031664 Abr 200728 Sep 2010Ethicon Endo-Surgery, Inc.Method for plicating and fastening gastric tissue
US78156534 Abr 200719 Oct 2010Ethicon Endo-Surgery, Inc.Method for plicating and fastening gastric tissue
US782881231 Mar 20069 Nov 2010Ethicon Endo-Surgery, Inc.Surgical suturing apparatus with needle release system
US783323631 Mar 200616 Nov 2010Ethicon Endo-Surgery, Inc.Surgical suturing apparatus with collapsible vacuum chamber
US78332808 Abr 200816 Nov 2010Barosense, Inc.Satiation devices and methods
US784616931 Mar 20067 Dic 2010Ethicon Endo-Surgery, Inc.Adjustable vacuum chamber for a surgical suturing apparatus
US786257220 Sep 20054 Ene 2011Endoevolution, LlcApparatus and method for minimally invasive suturing
US78625822 May 20064 Ene 2011Ethicon Endo-Surgery, Inc.Suture management
US78750424 May 200725 Ene 2011Ethicon Endo-Surgery, Inc.Suture anchor loader
US788755431 Mar 200615 Feb 2011Ethicon Endo-Surgery, Inc.Surgical suturing apparatus with needle position indicator
US78922451 Dic 200322 Feb 2011Liddicoat John RApparatus and method for manipulating tissue
US78968902 Sep 20051 Mar 2011Ethicon Endo-Surgery, Inc.Method and apparatus for endoscopically performing gastric reduction surgery in a single step
US78968945 Ago 20051 Mar 2011Ethicon Endo-Surgery, Inc.Apparatus for single pass gastric restriction
US79188669 Mar 20075 Abr 2011Boston Scientific Scimed, Inc.Devices and related methods for securing a tissue fold
US793166111 Ago 200426 Abr 2011Usgi Medical, Inc.Apparatus and methods for performing transluminal gastrointestinal procedures
US794288710 Jun 200417 May 2011Endogastric Solutions, Inc.Transoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method
US79511594 Abr 200731 May 2011Ethicon Endo-Surgery, Inc.Method for plicating and fastening gastric tissue
US7972355 *24 Oct 20065 Jul 2011Boston Scientific Scimed, Inc.Emboli and thrombi filter device and method of using the same
US797655331 Mar 200612 Jul 2011Ethicon Endo-Surgery, Inc.Surgical suturing apparatus with detachable handle
US797655517 Jul 200812 Jul 2011Endoevolution, LlcApparatus and method for minimally invasive suturing
US799335421 Oct 20109 Ago 2011Endoevolution, LlcDevices and methods for minimally invasive suturing
US799814830 Jun 200616 Ago 2011Olympus CorporationEndoscopic instruments
US800688630 Jun 200930 Ago 2011Medigus Ltd.Stapler for endoscopes
US80295225 Ago 20054 Oct 2011Ethicon Endo-Surgery, Inc.Method and apparatus for sealing a gastric opening
US80295355 Ago 20054 Oct 2011Ethicon Endo-Surgery, Inc.Fasteners for use with gastric restriction
US803406222 Abr 200811 Oct 2011Ethicon Endo-Surgery, Inc.Methods and devices for placement of an intra-abdominal or intra-thoracic appliance through a natural body orifice
US806673722 Mar 200629 Nov 2011Endoevolution, LlcNeedle for suturing instrument
US808375810 Oct 200727 Dic 2011Hourglass Technologies, Inc.Methods and devices for treating obesity and GERD by intussuscepting a portion of stomach tissue
US809247221 Feb 200810 Ene 2012Cerier Jeffrey CMethods and devices for endoscopic treatment of organs
US809247422 Abr 200810 Ene 2012Ethicon Endo-Surgery, Inc.Methods and devices for placement of an intra-abdominal or intra-thoracic appliance through a natural body orifice
US81009255 Nov 200824 Ene 2012Hourglass Technologies, Inc.Methods and devices for treating obesity and GERD by intussuscepting a portion of stomach tissue
US811882031 Mar 200621 Feb 2012Ethicon Endo-Surgery, Inc.Method for instrument insertion through a body orifice
US812376420 Nov 200928 Feb 2012Endoevolution, LlcApparatus and method for minimally invasive suturing
US812864518 Feb 20056 Mar 2012Medigus Ltd.Stapler for endoscopes
US813325418 Sep 200913 Mar 2012Tyco Healthcare Group LpIn vivo attachable and detachable end effector assembly and laparoscopic surgical instrument and methods therefor
US81475065 Ago 20053 Abr 2012Ethicon Endo-Surgery, Inc.Method and clamp for gastric reduction surgery
US815282121 Feb 200810 Abr 2012C.R. Bard, Inc.Endoscopic tissue apposition device with multiple suction ports
US81669784 Oct 20071 May 2012Ethicon Endo-Surgery, Inc.Methods and systems for manipulating tissue
US81728579 Mar 20058 May 2012Davol, Inc.Endoscopic tissue apposition device and method of use
US81777945 Oct 200715 May 2012Tyco Healthcare Group LpFlexible endoscopic stitching devices
US8206386 *7 Oct 200926 Jun 2012Lenr, Inc.Methods and devices for removing omental tissue
US82090374 Oct 200726 Jun 2012Ethicon Endo-Surgery, Inc.Methods and devices for medical treatment
US821114223 Mar 20063 Jul 2012Ortiz Mark SMethod for hybrid gastro-jejunostomy
US822143817 Feb 200617 Jul 2012Ethicon Endo-Surgery, Inc.Lumen reduction methods and devices
US822667122 Abr 200924 Jul 2012Ethicon Endo-Surgery, Inc.Methods and devices for providing direction to surgical tools
US82466375 Oct 200721 Ago 2012Tyco Healthcare Group LpFlexible endoscopic stitching devices
US82520065 Ago 200528 Ago 2012Ethicon Endo-Surgery, Inc.Single pass gastric restriction with a corkscrew style wall anchor
US825737326 Jun 20074 Sep 2012Medigus Ltd.Device for performing a fundoplication surgical procedure
US82573745 Nov 20084 Sep 2012Hourglass Technologies, Inc.Methods and devices for treating obesity and GERD by intussuscepting a portion of stomach tissue
US82929055 Oct 200723 Oct 2012Tyco Healthcare Group LpFlexible endoscopic stitching devices
US82929065 Oct 200723 Oct 2012Tyco Healthcare Group LpFlexible endoscopic stitching devices
US832882720 Ago 200711 Dic 2012Medigus Ltd.Stapler for endoscopes
US833751417 Jun 201025 Dic 2012Endogastric Solutions, Inc.Slitted tissue fixation devices and assemblies for deploying the same
US83375155 Oct 200725 Dic 2012Covidien LpFlexible endoscopic stitching devices
US83610871 Mar 201129 Ene 2013Boston Scientific Scimed, Inc.Devices and related methods for securing a tissue fold
US838863220 Feb 20085 Mar 2013C.R. Bard, Inc.Tissue capturing and suturing device and method
US843516912 Nov 20107 May 2013Olympus CorporationEndoscope and endoscopic suturing instrument for treatment of gastroesophageal reflux disease
US84352622 Dic 20107 May 2013Ethicon Endo-Surgery, Inc.Suture management
US845462813 May 20044 Jun 2013Syntheon, LlcSurgical fastener aligning instrument particularly for transoral treatment of gastroesophageal reflux disease
US84602755 Oct 200711 Jun 2013Covidien LpFlexible endoscopic stitching devices
US846997317 Jul 200825 Jun 2013Endoevolution, LlcApparatus and method for sternotomy closure
US84699764 Oct 200725 Jun 2013Ethicon Endo-Surgery, Inc.Methods of organ reconfiguration
US84754535 Mar 20102 Jul 2013Covidien LpEndoscopic vessel sealer and divider having a flexible articulating shaft
US849668431 Oct 200730 Jul 2013Ethicon Endo-Surgery, Inc.Method for deploying a device for gastric volume reduction
US850075631 Mar 20066 Ago 2013Ethicon Endo. Surgery, Inc.Quick load mechanism for a surgical suturing apparatus
US854073516 Dic 201024 Sep 2013Apollo Endosurgery, Inc.Endoscopic suture cinch system
US855112013 Sep 20128 Oct 2013C.R. Bard, Inc.Tissue capturing and suturing device and method
US857322615 Abr 20115 Nov 2013Usgi Medical, Inc.Apparatus and methods for performing transluminal gastrointestinal procedures
US861718918 Feb 201131 Dic 2013John R. LiddicoatApparatus and method for manipulating tissue
US8623015 *16 May 20127 Ene 2014Lenr, Inc.Methods and devices for removing omental tissue
US86230483 Ago 20117 Ene 2014Endoevolution, LlcSuturing instrument
US862854328 Feb 201114 Ene 2014Boston Scientific Scimed, Inc.Method and apparatus for endoscopic repair of the lower esophageal sphincter
US863199130 May 200721 Ene 2014Ethicon Endo-Surgery, Inc.Surgical instrument
US863675223 Abr 201228 Ene 2014Covidien LpFlexible endoscopic stitching devices
US864172831 Mar 20064 Feb 2014Ethicon Endo-Surgery, Inc.Attachment apparatus for coupling with an endoscope
US864172913 Jul 20064 Feb 2014Creighton UniversitySystems and techniques for minimally invasive gastrointestinal procedures
US87027349 May 201122 Abr 2014Endogastric Solutions, Inc.Transoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method
US87152945 Ago 20056 May 2014Ethicon Endo-Surgery, Inc.Gastric instrument sleeve to prevent cross contamination of stomach content and provide fixation and repeatable path
US87216405 Oct 200713 May 2014Covidien LpEndoscopic vessel sealer and divider having a flexible articulating shaft
US20100210999 *7 Oct 200919 Ago 2010Lenr, Inc.Methods and devices for removing omental tissue
US20100234886 *24 May 201016 Sep 2010Norman GodinMETHOD FOR SECURING MEDICAL DEVICES TO TREAT OBESITY, GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) AND IRRITABLE BOWEL SYNDROME (iBS) REVERSIBLY
US20100241146 *3 Jun 201023 Sep 2010Stack Richard SDevices and methods for retaining a gastro-esophageal implant
US20110087251 *21 Dic 201014 Abr 2011Kraemer Stefan J MApparatus and method for manipulating stomach tissue and treating gastroesophageal reflux disease
US20120109159 *23 Sep 20113 May 2012Gary JordanTissue closure
EP2258277A14 Oct 20078 Dic 2010NDO Surgical, Inc.System for gastric restriction
WO2004050971A2 *1 Dic 200317 Jun 2004William E CohnApparatus and method for manipulating tissue
WO2006023764A2 *18 Ago 20052 Mar 2006Endo Gastric Solutions IncTransoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method
WO2011146853A220 May 201124 Nov 2011Barosense, Inc.Tissue-acquisition and fastening devices and methods
Eventos legales
FechaCódigoEventoDescripción
18 May 2011FPAYFee payment
Year of fee payment: 8
21 May 2010ASAssignment
Owner name: ETHICON ENDO-SURGERY, INC.,OHIO
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NDO SURGICAL, INC.;US-ASSIGNMENT DATABASE UPDATED:20100525;REEL/FRAME:24411/991
Effective date: 20100502
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NDO SURGICAL, INC.;US-ASSIGNMENT DATABASE UPDATED:20100524;REEL/FRAME:24411/991
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NDO SURGICAL, INC.;REEL/FRAME:24411/991
Owner name: ETHICON ENDO-SURGERY, INC., OHIO
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NDO SURGICAL, INC.;REEL/FRAME:024411/0991
18 Dic 2006FPAYFee payment
Year of fee payment: 4
7 Mar 2000ASAssignment
Owner name: NDO SURICAL, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAUFER, MICHAEL D.;CERIER, JEFFREY C.;CRUZ, AMOS G.;REEL/FRAME:010612/0524;SIGNING DATES FROM 20000306 TO 20000307